Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3010156	s-hcrp	mg/l (mg/l)	5099	6474	0.00%
3010156	s-hcrp	— (—)	4767	5999	100.00%	Distribution not available
3010156	s-hs-crp	mg/l (mg/l)	3777	8470	0.04%
3010156	s-ucrp	mg/l (mg/l)	1929	3232	0.00%
3010156	s-c-reaktiivinenproteiini,herkkä	mg/l (mg/l)	736	809	0.00%
3010156	p-hs-crp	mg/l (mg/l)	501	1315	0.00%
3010156	s-hs-crp	— (—)	376	516	100.00%	Distribution not available
3010156	s-ucrp	— (—)	358	418	100.00%	Distribution not available
3010156	s-hscrp	mg/l (mg/l)	319	395	0.00%
3010156	c-reaktiivinenproteiini,vieritutkimus	mg/l (mg/l)	310	487	0.00%
3010156	c-reaktiivinenproteiini,herkkä	mg/l (mg/l)	176	252	0.00%
3010156	c-reaktiivinenproteiini,vieritutkimusnordlab	mg/l (mg/l)	74	82	0.00%
3010156	c-reaktiivinenproteiini,pika	mg/l (mg/l)	71	81	0.00%
3010156	s-c-reaktiivinenproteiini,pika	mg/l (mg/l)	65	76	0.00%
3010156	p-hs-crp	— (—)	53	66	100.00%	Distribution not available
3010156	s-hscrp	— (—)	14	16	100.00%	Distribution not available
3010156	s-hs-crp	mg/l______ (mg/l)	5	15	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other nutritional deficiencies

2548

12631

1.90

185.30

2.0

1.6

5.31

3.98

mg/l

5.76

2369

8855

Depression

3316

12920

1.76

178.26

1.7

3.91

4.27

mg/l

1.28

2768

9098

Obesity

2390

12334

1.88

169.35

2.0

1.6

5.34

4.00

mg/l

5.58

2256

8639

Mood [affective] disorders

3422

13044

1.72

168.76

1.7

3.94

4.28

mg/l

1.10

2853

9196

Obesity and other hyperalimentation

2395

12365

1.88

168.62

2.0

1.6

5.34

4.00

mg/l

5.60

2260

8662

Mood disorders

3426

13046

1.72

168.44

1.7

3.96

4.28

mg/l

1.04

2855

9199

Obesity, other/unspecified

1445

6780

2.23

163.16

2.3

1.7

5.20

3.96

mg/l

2.65

1364

4754

Obesity due to excess calories

1866

9719

1.99

157.31

2.1

1.6

5.33

4.03

mg/l

4.04

1768

6781

Recurrent or chronic depression

1614

5664

2.04

137.84

1.7

3.77

4.23

mg/l

0.98

1354

3827

Nonorganic sleeping disorders, excluding more controls

915

3942

2.44

127.41

1.6

1.7

3.28

4.15

mg/l

2.09

777

2681

Mood disorders, excluding more controls

3015

10970

1.65

125.55

1.7

4.03

4.26

mg/l

0.53

2527

7633

Myocarditis

305

705

4.85

124.10

12.7

1.4

3.14

3.64

mg/l

0.40

293

480

Anxiety (asthma-related co-morbidities)

2312

10341

1.74

123.94

1.6

1.7

3.67

4.24

mg/l

2.32

1888

7173

All anxiety disorders

2387

11021

1.72

123.34

1.6

1.7

3.67

4.17

mg/l

2.08

1944

7763

Neurotic, stress-related and somatoform disorders

2989

12894

1.63

122.89

1.8

1.7

3.88

4.22

mg/l

1.09

2442

9174

Anxiety disorders

2999

12936

1.62

121.14

1.8

1.7

3.89

4.22

mg/l

1.01

2449

9210

Sleep apnoea

2741

10945

1.61

105.33

1.9

1.7

5.28

4.00

mg/l

4.25

2406

7849

Any death

305

6997

0.30

104.86

1.9

1.7

9.36

4.32

mg/l

4.13

276

5241

Sleep apnoea, including avohilmo

2949

11487

1.58

104.55

1.9

1.7

5.13

3.94

mg/l

4.30

2533

8195

Anxiety disorders, excluding more controls

2656

10754

1.61

102.44

1.8

1.7

3.95

4.19

mg/l

0.56

2181

7466

Nonorganic sleeping disorders

915

4325

2.21

101.95

1.6

1.7

3.28

4.31

mg/l

3.12

777

3118

Generalized anxiety disorder

797

3568

2.35

101.65

1.6

3.08

4.17

mg/l

3.40

654

2400

Behavioural syndromes associated with physiological disturbances and physical factors

2937

13022

1.55

98.70

1.6

1.7

3.64

4.35

mg/l

3.80

2310

9377

Other anxiety disorders

1796

9065

1.73

95.68

1.7

1.6

3.63

4.20

mg/l

2.07

1469

6294

Sleep disorders

2834

12892

1.54

92.17

1.6

1.7

3.66

4.33

mg/l

3.37

2228

9275

Special screening examination for infectious and parasitic diseases

1167

4460

1.98

91.81

1.5

1.6

3.20

3.76

mg/l

1.36

807

2955

Sleep disorders (combined)

3162

11189

1.50

85.97

1.7

1.6

4.44

4.09

mg/l

0.72

2563

7761

Other antidepressants

2918

9949

1.52

84.56

1.7

4.53

4.28

mg/l

0.47

2353

6886

Insomnia

2778

13080

1.50

80.63

1.6

1.7

3.58

4.30

mg/l

3.93

2173

9421

Sarcoidosis

469

1855

2.66

78.99

8.6

1.5

3.88

4.55

mg/l

0.64

430

1395

Selective serotonin reuptake inhibitors

2824

9960

1.49

76.22

1.7

4.04

4.28

mg/l

0.56

2255

6895

Hyperkinetic disorders, excluding more controls

604

2637

2.24

68.51

1.5

1.6

3.72

3.90

mg/l

0.21

490

1581

Restless leg syndrome

472

2131

2.31

59.06

1.8

1.7

3.11

4.34

mg/l

2.12

409

1592

Certain disorders involving the immune mechanism

569

2841

2.07

54.66

7.4

1.5

4.25

4.43

mg/l

0.15

512

2105

Depression or dysthymia

1802

6570

1.52

53.48

1.8

1.7

4.13

4.29

mg/l

0.23

1460

4500

Episodal and paroxysmal disorders

3038

11442

1.36

49.14

1.8

1.6

4.53

3.92

mg/l

1.54

2440

7946

Hyperkinetic disorders

606

3234

1.90

44.63

1.5

1.6

3.71

3.94

mg/l

0.31

492

2168

Continuous positive airway pressure

564

2480

1.95

44.59

2.3

1.4

4.59

3.41

mg/l

1.85

511

1638

Disturbance of activity and attention

584

3102

1.91

43.83

1.5

1.6

3.68

3.93

mg/l

0.35

472

2062

Personality disorders, excluding more controls

876

5345

1.68

43.07

1.7

3.65

4.26

mg/l

1.46

754

3579

Other sleep disorders

361

1664

2.25

43.02

1.9

1.7

3.34

4.04

mg/l

0.84

321

1152

Chronic diseases of tonsils and adenoids

2310

10665

1.38

42.96

1.7

3.80

4.11

mg/l

0.82

1726

7681

Other extrapyramidal and movement disorders in other diseases

619

3443

1.84

42.68

1.8

1.7

3.14

4.60

mg/l

4.01

521

2565

Benzodiazepine use

2753

14005

1.34

42.53

1.7

4.24

4.25

mg/l

0.02

2267

10085

Depression medications

1119

3563

1.61

41.91

1.7

1.3

4.17

3.40

mg/l

1.82

881

2085

KRA_PSY_EATING, excluding more controls

365

1717

2.21

40.70

1.7

1.6

3.63

4.20

mg/l

0.50

287

1046

Disorder of the sleep-wake schedule

111

281

4.46

40.67

1.8

1.7

3.85

3.84

mg/l

0.01

103

195

Triptan medication for migraine, single purchase ok

2337

11787

1.36

39.59

1.8

1.7

3.89

4.20

mg/l

0.68

1755

8549

Migraine, single triptan purchase ok & required. ICD-code if available is included

2337

11787

1.36

39.59

1.8

1.7

3.89

4.20

mg/l

0.68

1755

8549

Migraine

1653

9091

1.44

39.46

1.8

1.6

3.64

3.87

mg/l

0.52

1271

6307

Medical observation and evaluation for suspected diseases and conditions

1796

6510

1.43

38.65

1.8

1.6

4.49

3.93

mg/l

1.04

1426

4490

Sleep disorders, other/unspecified

183

660

3.00

37.88

1.8

1.9

3.05

4.83

mg/l

1.07

168

471

Other diseases of upper respiratory tract

2804

11164

1.32

37.53

1.7

4.40

4.26

mg/l

0.22

2111

8085

Persistent mood disorders

554

3110

1.83

37.27

1.7

3.91

4.48

mg/l

0.76

487

2205

Diagnoses used for exclusion with ILD

564

3182

1.81

37.02

7.5

1.5

5.37

4.67

mg/l

0.51

519

2375

Pain in joint

1671

7350

1.41

35.45

1.8

1.6

4.42

4.01

mg/l

0.67

1314

5083

Symptoms and signs involving the circulatory and respiratory systems

2864

11086

1.31

35.31

1.8

1.6

4.70

3.95

mg/l

1.97

2231

7837

Phobic anxiety disorders

502

2782

1.86

35.29

1.5

1.6

3.78

4.17

mg/l

0.42

415

1863

Adjustment and management of implanted device

338

1643

2.10

34.74

9.3

1.6

4.17

4.47

mg/l

0.18

307

1224

Chronic rhinitis, nasopharyngitis and pharyngitis

910

5947

1.56

33.65

1.7

4.00

4.14

mg/l

0.13

698

4355

Obesity related asthma

937

6177

1.54

33.34

2.1

1.7

6.01

3.93

mg/l

3.02

855

4562

General examination and investigation of persons without complaint and reported diagnosis

1732

6510

1.40

33.31

1.8

1.6

5.53

3.93

mg/l

3.99

1421

4490

Examination and observation for other reasons

1604

6498

1.41

32.95

1.9

1.6

4.12

3.93

mg/l

0.24

1267

4485

Headache

1961

11349

1.35

32.61

1.7

1.6

4.19

3.93

mg/l

0.54

1548

8052

Disorders of conjunctiva

2324

13818

1.32

32.50

1.7

4.19

4.17

mg/l

0.04

1752

10078

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

845

4772

1.58

32.33

1.5

1.6

3.93

3.96

mg/l

0.03

678

3161

Hypothyroidism (congenital or acquired)

937

3412

1.57

32.23

2.0

1.3

4.05

3.44

mg/l

1.11

748

2016

Hypothyroidism, levothyroxine purchases

932

3408

1.56

31.64

1.9

1.3

3.97

3.44

mg/l

0.91

745

2015

Hypothyroidism and >3 levothyroxin purchases

932

3408

1.56

31.64

1.9

1.3

3.97

3.44

mg/l

0.91

745

2015

Social phobias

342

1744

2.04

31.49

1.5

1.6

3.95

4.19

mg/l

0.16

276

1161

Conjunctivitis

2170

13360

1.32

31.38

1.7

4.19

4.16

mg/l

0.05

1634

9727

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2935

0.32

30.85

1.7

6.00

4.79

mg/l

0.49

2189

Panic disorder

529

3105

1.75

30.80

1.6

3.91

4.29

mg/l

0.40

429

2105

Hypothyroidism, other/unspecified

2318

11785

1.30

29.85

1.9

1.6

4.41

4.27

mg/l

0.24

1863

8538

Bipolar affective disorders

600

3675

1.67

29.62

1.7

4.01

4.33

mg/l

0.36

514

2523

Abnormalities of heart beat

912

5934

1.51

29.57

2.1

1.6

4.35

4.13

mg/l

0.21

716

4249

Hypothyreosis and Thyroxine purchase for inclusion criteria

2387

12175

1.30

29.13

1.9

1.6

4.46

4.22

mg/l

0.48

1917

8839

Extrapyramidal and movement disorders

792

5181

1.55

29.07

1.7

3.19

4.65

mg/l

5.63

651

3864

Disorders of adult personality and behaviour

930

6319

1.50

28.88

1.7

3.82

4.11

mg/l

0.54

798

4485

Personality disorders

876

5893

1.52

28.61

1.7

3.65

4.17

mg/l

1.29

754

4193

Any mental disorder

2777

11004

1.27

28.39

1.7

4.35

4.25

mg/l

0.16

2253

7661

Post-traumatic stress disorder

353

1895

1.94

28.05

1.7

1.6

3.90

4.25

mg/l

0.30

289

1260

Postmenopausal atrophic vaginitis

583

1899

1.70

28.01

1.6

1.8

2.98

4.78

mg/l

4.99

438

1479

Specific personality disorders

772

5108

1.55

27.38

1.7

3.82

4.19

mg/l

0.67

663

3634

Disorders of the thyroid gland

2437

12445

1.28

27.23

1.9

1.6

4.37

4.27

mg/l

0.18

1939

9024

Triptan medication for migraine, min. 3 purchases

1854

10592

1.33

26.98

1.7

3.74

4.14

mg/l

1.04

1399

7732

Pain and other conditions associated with female genital organs and menstrual cycle

711

3853

1.58

26.93

1.6

3.35

4.40

mg/l

4.04

545

2761

Abnormalities of breathing

2447

11061

1.28

26.02

1.8

1.6

4.98

3.95

mg/l

3.86

1992

7824

Endocrine, nutritional and metabolic diseases

2341

9276

1.29

25.78

1.9

1.5

4.95

3.73

mg/l

3.58

1946

6085

Allergic conjunctivitis

1663

12179

1.33

25.72

1.7

4.21

4.11

mg/l

0.13

1234

8925

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1601

11622

1.34

25.53

1.7

4.23

4.12

mg/l

0.14

1185

8492

Iron deficiency

161

667

2.60

25.47

1.7

4.42

2.98

mg/l

0.73

121

433

Irritable bowel syndrome

786

5297

1.51

25.36

1.7

3.75

4.18

mg/l

0.65

625

3813

Neurological diseases

2384

9471

1.27

24.58

1.8

1.6

4.85

3.76

mg/l

2.67

1888

6446

Coxibs

647

2148

1.60

24.54

1.6

1.7

4.10

4.49

mg/l

0.48

505

1353

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1281

9125

1.37

24.24

1.7

3.92

4.33

mg/l

0.70

987

6683

Stroke, including SAH

562

6295

0.63

24.24

1.7

1.8

4.99

4.54

mg/l

0.30

455

4746

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2857

12311

1.24

23.86

1.8

1.6

5.68

3.83

mg/l

6.77

2261

8818

Chronic sinusitis

1090

7873

1.40

23.79

1.8

1.7

4.25

4.27

mg/l

0.02

869

5778

Other chronic obstructive pulmonary disease, including avohilmo

427

5782

0.60

23.66

1.7

8.72

4.50

mg/l

4.41

376

4325

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2610

13522

1.25

23.35

1.8

1.6

4.78

4.05

mg/l

2.11

2059

9782

Hypothyroidism, strict autoimmune

1993

10259

1.29

23.19

1.9

1.6

4.45

4.07

mg/l

0.81

1599

7337

Exposure to other specified factors

2151

14727

1.26

22.62

1.6

1.7

3.97

4.25

mg/l

0.57

1641

10739

Emotionally unstable personality disorder

450

2757

1.68

22.57

1.6

1.7

4.03

4.21

mg/l

0.19

387

1937

Use of hypnotics and sedatives

2680

12434

1.24

22.52

1.7

4.20

4.29

mg/l

0.16

2179

9107

Pain in throat and chest

2269

10726

1.26

22.31

2.0

1.6

4.86

3.97

mg/l

1.84

1800

7607

Stroke, excluding SAH

504

5701

0.63

22.21

1.7

4.87

4.64

mg/l

0.13

412

4299

Pacemaker

528

3116

1.59

21.91

7.3

1.5

5.93

4.93

mg/l

0.76

486

2331

Acute upper respiratory infections

2617

12749

1.24

21.89

1.8

1.7

4.99

4.04

mg/l

3.04

2054

9208

Hypothyroidism, strict autoimmune, 3 medication purchases required

2140

11462

1.26

21.84

1.8

1.6

4.43

4.21

mg/l

0.41

1721

8322

Nightmares

9.36

21.69

1.4

2.0

2.71

2.64

mg/l

0.02

Eating disorder

365

2139

1.77

21.69

1.7

1.6

3.63

4.12

mg/l

0.54

287

1482

Diabetes, insulin treatment (Kela reimbursement)

1641

12537

0.77

21.58

1.9

1.7

5.47

4.12

mg/l

4.64

1493

9142

Vasomotor and allergic rhinitis

1095

7884

1.38

21.37

1.6

4.39

4.14

mg/l

0.35

823

5645

Other menopausal disorders

663

2447

1.54

21.17

1.7

1.8

2.95

4.58

mg/l

5.80

489

1857

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2279

0.36

20.72

1.5

1.7

9.87

4.87

mg/l

1.98

1692

Female infertility

885

3749

1.44

20.70

1.5

1.7

4.12

4.48

mg/l

0.47

628

2699

Cardiomyopathy, other and unspecified

184

874

2.17

20.57

7.3

1.5

5.45

5.20

mg/l

0.07

168

630

Genitourinary diseases

1453

5545

1.33

20.33

1.7

5.13

3.98

mg/l

1.32

1051

3899

COPD

322

4451

0.58

20.32

1.8

1.7

10.50

4.28

mg/l

4.97

283

3276

Periodontitis

1654

13386

0.78

20.12

1.8

1.7

6.07

4.05

mg/l

4.27

1364

9846

Cystitis

2129

10175

1.25

19.90

1.7

4.18

4.30

mg/l

0.18

1648

7438

Other reaction to severe stress, and adjustment disorders

1073

7974

1.36

19.85

2.0

1.7

4.30

4.27

mg/l

0.03

900

5586

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1756

14711

0.79

19.84

2.0

1.6

6.75

3.84

mg/l

10.43

1475

10680

Ischaemic Stroke, excluding all haemorrhages

451

5195

0.63

19.84

1.7

4.99

4.74

mg/l

0.13

368

3922

COPD, early/later onset

304

4372

0.58

19.75

1.7

9.87

4.69

mg/l

3.80

267

3298

Female infertility, cervical, vaginal, other or unspecified origin

814

3666

1.44

19.70

1.5

1.7

3.82

4.48

mg/l

1.20

572

2644

Malignant neoplasm of digestive organs

300

3946

0.58

19.69

1.4

1.7

4.80

4.64

mg/l

0.09

252

2953

COPD, hospital admissions

300

4335

0.58

19.58

1.7

9.97

4.72

mg/l

3.80

263

3272

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

105

2098

0.41

19.58

2.2

1.7

5.76

4.86

mg/l

0.30

1548

Chronic periodontitis, including avohilmo

1656

13362

0.78

19.47

1.8

1.7

6.05

4.05

mg/l

4.17

1365

9829

Neurological diseases, wide definition

999

3644

1.40

19.19

1.8

1.5

4.82

3.12

mg/l

2.32

794

2204

Malignant neoplasm of digestive organs, including Hilmo

362

4340

0.61

19.15

1.4

1.8

6.14

4.60

mg/l

1.10

303

3255

Other chronic obstructive pulmonary disease

303

4219

0.58

19.14

1.7

9.90

4.26

mg/l

4.40

266

3122

Dipeptidyl peptidase 4 (DPP-4) inhibitors

535

6265

0.66

18.95

2.3

1.7

6.15

4.40

mg/l

2.15

473

4621

Malignant neoplasm of respiratory system and intrathoracic organs

1813

0.37

18.73

2.2

1.7

5.58

4.77

mg/l

0.25

1352

Atherosclerosis, excluding cerebral and coronary sclerosis

218

3154

0.54

18.32

2.0

1.7

6.93

5.16

mg/l

0.90

188

2390

Other specific joint derangements/joint disorders

2098

10602

1.24

18.31

1.8

1.6

4.67

4.00

mg/l

1.55

1658

7444

Peripheral artery disease

259

3585

0.57

18.25

1.7

6.85

4.99

mg/l

1.21

227

2713

Other medical care

496

6235

0.66

17.98

1.5

8.51

4.15

mg/l

5.14

398

4562

Deviated nasal septum

707

4988

1.43

17.87

1.6

1.8

4.12

4.43

mg/l

0.25

540

3662

Migraine without aura

671

4708

1.45

17.85

1.8

1.6

3.83

4.00

mg/l

0.19

522

3244

AV-block

295

1452

1.76

17.79

8.0

1.5

4.76

5.16

mg/l

0.16

273

1055

Psychiatric diseases

2366

9722

1.23

17.71

1.7

4.37

4.30

mg/l

0.10

1881

6726

Eating disorders

385

2411

1.64

17.70

1.7

1.6

3.51

4.19

mg/l

0.92

305

1693

Other disorders of breast

394

2481

1.63

17.68

1.4

1.7

3.32

4.11

mg/l

1.27

283

1827

Acute upper respiratory infections of multiple and unspecified sites

2022

11987

1.24

17.68

1.8

1.7

5.33

3.98

mg/l

4.34

1574

8610

Seborrhoeic keratosis

477

3128

1.55

17.62

1.5

1.7

5.53

4.64

mg/l

0.44

351

2361

Lyme disease, including avohilmo

771

5553

1.41

17.50

1.6

1.7

3.14

4.38

mg/l

3.31

554

4145

Lyme disease

771

5553

1.41

17.50

1.6

1.7

3.14

4.38

mg/l

3.31

554

4145

Cardiomyopathy

336

2031

1.68

17.48

5.8

1.5

7.04

4.82

mg/l

1.68

308

1477

Persons encountering health services in other circumstances, wide

2861

12314

1.20

17.36

1.9

1.6

5.45

3.83

mg/l

5.89

2268

8821

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1099

4130

1.35

17.32

1.8

1.5

4.45

3.67

mg/l

0.72

829

2707

Malignant neoplasm of bronchus and lung, including Hilmo

1779

0.39

17.22

2.5

1.7

4.94

4.85

mg/l

0.03

1330

Pneumonia, organism unspecified

1588

13623

0.79

17.21

2.0

1.6

6.92

3.82

mg/l

10.22

1340

9888

Pneumonias (Asthma/COPD co-morbidities)

1845

14841

0.81

17.21

2.0

1.6

6.61

3.82

mg/l

10.28

1534

10742

Other headache syndromes

1074

8132

1.33

17.16

1.8

1.6

3.73

3.95

mg/l

0.35

856

5728

Somatoform disorder

432

2803

1.57

16.95

1.7

4.24

4.29

mg/l

0.03

357

2004

Other spirochaetal diseases

775

5622

1.40

16.87

1.6

1.7

3.20

4.37

mg/l

3.03

557

4202

Gastro-oesophageal reflux disease

1599

10763

1.26

16.86

1.8

1.7

4.70

4.21

mg/l

0.56

1301

7950

Anaemias

719

3265

1.43

16.85

2.0

1.3

5.34

3.44

mg/l

3.25

589

1949

Spirochaetal infections, other/unspecified, including avohilmo

773

5607

1.40

16.83

1.6

1.7

3.13

4.36

mg/l

3.30

556

4188

Bulimia nervosa (incl. atypical)

156

762

2.17

16.75

1.8

1.7

3.50

3.53

mg/l

0.02

126

516

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1585

11753

0.79

16.74

1.9

1.6

5.44

3.96

mg/l

5.27

1448

8420

Lung cancer and mesothelioma

1777

0.40

16.54

2.5

1.5

5.00

3.74

mg/l

0.47

1275

Cerebrovascular diseases

836

7842

0.73

16.53

1.7

1.8

4.56

4.50

mg/l

0.05

678

5898

Intestinal infectious diseases, including avohilmo, including avohilmo

2844

13333

1.19

16.50

1.8

1.6

4.88

4.07

mg/l

1.86

2231

9648

COPD (mode)

223

3080

0.56

16.46

1.7

1.5

10.76

3.56

mg/l

5.11

195

2211

All pneumoniae

1869

14865

0.81

16.45

2.0

1.6

6.64

3.82

mg/l

10.56

1555

10754

Other spirochaetal diseases, including avohilmo

781

5705

1.39

16.30

1.6

1.7

3.18

4.36

mg/l

3.12

562

4259

Noninflammatory disorders of female genital tract

1086

4116

1.34

16.30

1.6

4.12

4.41

mg/l

0.20

785

2964

Dermatitis and eczema

2802

13976

1.19

16.29

1.7

4.84

4.11

mg/l

1.72

2160

10156

Acetic acid derivatives and related substances

595

2096

1.48

16.25

1.8

1.7

4.08

4.53

mg/l

0.37

458

1328

Diseases of male genital organs

996

3736

1.35

16.25

1.7

4.24

4.55

mg/l

0.25

732

2683

Malignant neoplasm of bronchus and lung

1519

0.36

16.22

2.4

1.7

4.48

4.90

mg/l

0.13

1140

Other eating disorders

202

1089

1.93

16.14

1.6

3.74

3.96

mg/l

0.17

166

736

Antihypertensive medication - note that there are other indications

1966

8367

1.24

16.13

2.0

1.4

4.65

3.36

mg/l

3.78

1582

5457

Fenamates

343

1428

1.66

16.12

1.5

1.7

3.37

4.48

mg/l

1.74

262

929

Endometriosis

879

3768

1.37

15.94

1.6

1.7

3.81

4.45

mg/l

1.23

644

2736

Chronic laryngitis and laryngotracheitis

319

1961

1.66

15.74

1.9

1.7

3.79

4.64

mg/l

0.83

238

1451

Functional dyspepsia

641

4567

1.42

15.58

1.9

1.7

5.50

4.14

mg/l

1.25

504

3344

Diseases of the eye and adnexa

2276

9449

1.22

15.57

1.8

1.6

4.36

4.08

mg/l

0.35

1709

6715

Other disorders of lacrimal gland

839

6245

1.36

15.53

2.0

1.7

4.65

4.37

mg/l

0.24

676

4672

COPD, hospital admissions 1, only main diagnosis

193

3002

0.55

15.48

1.7

12.15

4.74

mg/l

3.82

172

2260

Symptoms and signs involving the skin and subcutaneous tissue

1737

13364

1.24

15.41

1.8

1.7

4.76

4.24

mg/l

0.80

1338

9885

Diseases of arteries, arterioles and capillaries

700

7029

0.72

15.13

1.8

1.7

5.24

4.53

mg/l

0.75

563

5266

Other bacterial diseases

1525

12514

0.80

15.12

2.0

1.7

6.70

3.95

mg/l

8.17

1271

9208

Later onset COPD

1611

0.41

15.07

1.4

1.6

10.71

4.99

mg/l

1.08

1232

Bacterial pneumonia, not elsewhere classified

403

5308

0.66

14.89

2.0

1.7

7.52

4.11

mg/l

3.31

344

3851

Bacterial pneumoniae

438

5673

0.67

14.86

2.0

1.7

7.41

4.10

mg/l

3.49

373

4116

Propionic acid derivatives

623

2193

1.44

14.81

1.8

1.7

3.73

4.51

mg/l

1.06

466

1380

Allergic rhinitis

903

6776

1.33

14.59

1.6

1.7

4.40

4.04

mg/l

0.49

678

4866

Reimbursement for rheumatic diseases

793

10488

0.74

14.59

1.9

1.7

7.15

4.07

mg/l

5.08

658

7790

Codeine or tramadol medication

2848

13176

1.18

14.44

1.8

1.6

4.99

4.04

mg/l

3.42

2354

9381

Liquid cancers, including Hilmo

311

4309

0.63

14.38

1.5

1.7

6.87

4.61

mg/l

1.63

253

3177

Caries of enamel

2470

13645

1.19

14.34

1.9

1.6

4.50

4.17

mg/l

0.48

1838

10009

Autism spe, excluding more controls

408

2.47

14.33

1.6

1.8

3.32

3.54

mg/l

0.14

249

Insulin medication

803

8845

0.75

14.31

2.0

1.7

5.81

4.15

mg/l

3.16

750

6305

Persons encountering health services for examination and investigation

1608

6510

1.25

14.20

1.7

1.6

5.10

3.93

mg/l

2.26

1223

4490

Use of pramipexole

411

2740

1.52

14.20

1.7

4.63

4.43

mg/l

0.12

355

2074

Tonsillectomy and adenotomy

1735

9897

1.23

14.15

1.7

4.03

4.08

mg/l

0.09

1272

7132

COPD, hospital admission 2, with asthma infections

189

2884

0.56

14.14

1.7

10.46

4.70

mg/l

3.01

174

2172

Disorders of lacrimal system

985

7479

1.31

14.06

2.0

1.7

4.41

4.38

mg/l

0.02

791

5595

Other bacterial diseases, including avohilmo

1822

13735

0.82

13.96

1.9

1.7

6.45

3.93

mg/l

7.01

1498

10035

Migraine without aura and triptan purchases

557

3966

1.43

13.87

1.8

1.6

3.56

4.24

mg/l

1.08

429

2841

Testicular dysfunction

117

548

2.22

13.86

1.8

3.86

5.12

mg/l

0.35

412

Sulfonylureas

176

2518

0.55

13.85

2.0

1.7

5.74

5.09

mg/l

0.24

156

1871

Cough

929

6659

1.31

13.66

2.0

1.6

4.53

4.14

mg/l

0.40

706

4834

Personal history of malignant neoplasm

228

1337

1.75

13.65

2.0

1.6

2.64

4.13

mg/l

2.21

193

999

Follow-up examination after treatment for conditions other than malignant neoplasms

1090

5659

1.29

13.65

1.7

1.6

3.52

3.91

mg/l

0.81

861

3931

COPD related to multimorbidity

255

3499

0.61

13.53

1.8

1.7

10.05

4.77

mg/l

3.43

229

2648

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

778

5796

1.34

13.27

1.6

1.7

4.72

4.18

mg/l

0.93

663

3883

Autoimmune diseases excluding thyroid diseases, strict definition

1887

12313

0.83

13.21

1.7

1.6

5.17

4.03

mg/l

3.17

1504

8717

COPD, hospital admissions 3, with asthma pneumonia sepsis

131

2169

0.51

13.16

1.7

11.81

4.69

mg/l

2.72

124

1642

Soft tissue disorders

2614

11410

1.18

13.09

1.7

1.6

4.11

4.18

mg/l

0.12

2071

8006

Asthma (mode)

1989

8707

1.21

12.99

1.8

1.4

5.49

3.48

mg/l

6.25

1588

6107

Chronic periodontitis, complicated

729

9405

0.75

12.97

1.7

6.28

4.35

mg/l

1.75

628

7048

Other soft tissue disorders, not elsewhere classified

2352

11329

1.19

12.96

1.8

1.6

4.33

4.19

mg/l

0.23

1905

7964

Later onset COPD, excluding more controls

1405

0.43

12.94

1.4

11.13

3.67

mg/l

1.52

1020

Codeine

2493

11462

1.18

12.93

1.8

1.6

4.69

3.69

mg/l

4.08

2056

7989

Oxycodone

404

5036

0.68

12.92

1.9

1.7

10.48

3.72

mg/l

7.42

358

3613

Injuries to the knee and lower leg

2967

13834

1.16

12.86

1.7

4.34

4.22

mg/l

0.22

2294

10025

Uterine polyps

634

2689

1.39

12.80

2.0

1.8

3.90

4.57

mg/l

0.94

496

2018

Disturbances of skin sensation

737

5556

1.34

12.72

1.8

1.7

3.85

4.28

mg/l

0.53

579

4077

Schizophrenia

158

2834

0.55

12.70

1.8

5.89

4.25

mg/l

1.35

139

2051

Exposure to unspecified factor

2518

14645

1.18

12.66

1.7

4.10

4.25

mg/l

0.29

1953

10653

Autoimmune diseases excluding thyroid diseases

1951

12590

0.83

12.58

1.7

1.6

5.13

4.04

mg/l

3.28

1554

8935

Transplanted organ and tissue status

225

1345

1.71

12.54

2.7

1.5

20.77

4.11

mg/l

10.57

210

966

Dentofacial anomalies [including malocclusion]

1953

12836

1.20

12.51

1.7

3.40

4.24

mg/l

4.78

1419

9406

Enthesopathies of lower limb, excluding foot

577

4201

1.39

12.49

1.7

1.8

4.02

4.14

mg/l

0.08

452

3074

Disorders of breast

1290

9187

1.25

12.36

1.6

1.7

3.77

4.09

mg/l

0.64

998

6824

Polyarthropathies

1098

8853

0.79

12.35

2.0

1.7

5.80

4.10

mg/l

3.75

916

6349

Atopic dermatitis

1715

11365

1.21

12.25

1.6

1.7

4.27

4.00

mg/l

0.48

1276

8192

Any gastric operation

2173

9202

1.19

12.23

1.8

1.6

5.26

3.69

mg/l

4.28

1703

6262

GASTRO-related operations

2173

9202

1.19

12.23

1.8

1.6

5.26

3.69

mg/l

4.28

1703

6262

Asthma, including avohilmo

2923

13930

1.16

12.17

1.7

5.42

3.94

mg/l

5.56

2298

10052

Influenza and pneumonia

2050

14924

0.84

12.16

1.9

1.6

6.40

3.80

mg/l

10.63

1686

10763

Dislocation, sprain and strain of joints and ligaments of knee

1658

12485

1.21

11.92

1.6

1.7

4.24

4.18

mg/l

0.06

1262

9026

Acute sinusitis

1427

10658

1.23

11.85

1.8

1.7

4.74

3.98

mg/l

1.51

1136

7634

Asthma (only as main-diagnosis)

1850

8657

1.20

11.71

1.8

1.4

5.54

3.47

mg/l

8.48

1458

6063

Elevated blood glucose level

194

1138

1.74

11.64

2.3

1.8

4.96

4.69

mg/l

0.13

176

837

Hypertrophy of breast

471

3362

1.43

11.62

1.7

3.69

4.04

mg/l

0.43

403

2498

Endometriosis of pelvic peritoneum

442

2829

1.44

11.60

1.6

1.7

4.09

4.65

mg/l

0.73

334

2075

Tinnitus

504

3636

1.40

11.55

1.5

1.7

3.90

4.49

mg/l

0.45

362

2713

Biological medication for rheuma

228

3630

0.62

11.55

1.5

1.7

7.12

4.16

mg/l

1.79

183

2635

Myalgia

622

4642

1.36

11.54

1.9

1.7

3.95

4.33

mg/l

0.44

502

3289

Anti-inflammatory and antirheumatic products, non-steroids

599

2193

1.39

11.51

1.7

3.60

4.51

mg/l

1.33

442

1380

Asthma (only as main-diagnosis), excluding more controls

1827

8465

1.20

11.42

1.8

1.4

5.56

3.43

mg/l

8.66

1439

5891

Wide developmental disorders, excluding more controls

108

517

2.12

11.40

1.5

1.7

3.11

3.84

mg/l

0.57

325

Bacterial pneumonia (organism specified)

471

5908

0.72

11.33

2.0

1.7

7.70

4.22

mg/l

3.66

396

4334

Cholecystectomy

1512

10642

1.21

11.32

1.9

1.7

5.65

4.22

mg/l

2.75

1301

7926

Unspecified/other endometriosis

299

1931

1.55

11.18

1.7

4.30

4.34

mg/l

0.03

221

1370

Other arrhythmias

1569

9747

1.21

11.13

2.6

1.4

4.27

4.18

mg/l

0.11

1232

7117

Inflammatory diseases of female pelvic organs

1716

9846

1.20

11.13

1.7

3.71

4.09

mg/l

1.24

1340

7197

Obsessive-compulsive disorder

225

1394

1.66

11.06

1.6

3.25

4.38

mg/l

1.07

189

915

Subjective visual disturbances

576

4281

1.36

10.99

2.0

1.7

3.89

4.47

mg/l

0.70

458

3147

Conduction disorders

521

3034

1.39

10.99

5.8

1.4

4.69

4.61

mg/l

0.04

458

2208

Excessive, frequent and irregular menstruation

977

4111

1.28

10.98

1.7

1.6

4.56

4.41

mg/l

0.09

755

2963

Pain (limb, back, neck, head abdominally)

1760

7381

1.20

10.98

1.8

1.6

4.64

4.02

mg/l

0.85

1349

5099

Diseases of the ear and mastoid process

2948

12885

1.15

10.94

1.7

4.21

mg/l

0.01

2225

9408

Conjunctivitis (acute, non atopic), including avohilmo

2443

12721

1.16

10.92

1.6

1.7

4.03

4.32

mg/l

0.58

1864

9270

Melanocytic naevi

766

5936

1.30

10.88

1.6

1.7

3.84

4.35

mg/l

0.68

528

4375

Hypogonadotropic hypogonadism

447

2.19

10.86

1.5

1.9

5.89

4.84

mg/l

0.17

328

Other diseases of intestines

2723

13180

1.16

10.86

1.7

4.46

4.18

mg/l

0.46

2131

9484

Diseases of oesophagus, stomach and duodenum

2577

13176

1.16

10.84

1.8

1.7

4.86

4.12

mg/l

1.56

2091

9583

Cardiac arrhythmias

1719

9257

1.20

10.80

2.8

1.4

4.35

3.60

mg/l

1.83

1360

6420

Pollen allergy

567

4164

1.36

10.75

1.6

3.82

4.20

mg/l

0.51

422

2950

Impacted cerumen

206

1257

1.67

10.62

1.6

1.7

3.67

4.51

mg/l

0.30

152

941

Asthma

1978

8657

1.18

10.61

1.8

1.4

5.76

3.47

mg/l

7.56

1587

6063

Agoraphobia

118

616

2.00

10.60

1.6

1.8

3.47

3.72

mg/l

0.19

100

396

Acute alcohol intoxication

272

4094

0.66

10.53

1.6

1.7

6.08

4.46

mg/l

1.30

242

2946

Rheumatoid arthritis

356

4516

0.69

10.52

1.9

1.7

7.80

4.10

mg/l

3.18

293

3283

Hypertrophy of breast in women and men

505

3710

1.38

10.49

1.7

3.92

4.14

mg/l

0.17

432

2759

Tumor necrosis factor alpha inhibitors

205

3260

0.62

10.40

1.5

1.7

7.39

4.08

mg/l

1.85

166

2362

Insulin, combination of fast acting with intermediate-acting or long-acting

803

9249

0.78

10.40

2.0

1.7

5.81

4.34

mg/l

2.58

750

6767

Asthma, excluding more controls

1942

8465

1.18

10.36

1.8

1.4

5.72

3.43

mg/l

7.40

1559

5891

Second line medication for Crohn's disease

916

11420

0.80

10.31

3.5

1.6

7.32

4.04

mg/l

5.63

767

8418

Polyp of the female genital tract

668

2868

1.33

10.22

1.9

1.7

4.03

4.58

mg/l

0.67

513

2142

Bacterial infection, other or unspecified, including avohilmo

743

7791

0.78

10.18

1.9

1.7

6.84

4.02

mg/l

4.63

613

5731

Other heart diseases, wide

2394

12558

1.16

10.07

2.8

1.4

4.45

4.08

mg/l

0.78

1917

9080

Migraine with aura

717

5575

1.30

9.97

1.8

1.6

3.81

3.98

mg/l

0.20

552

3836

Non-small cell lung cancer, including Hilmo

1339

0.44

9.96

2.5

1.7

4.45

4.63

mg/l

0.05

1003

Rheumatoid arthritis, including avohilmo

419

5774

0.72

9.91

1.9

1.7

7.54

4.20

mg/l

3.24

345

4323

Inflammatory diseases of prostate (prostatitis)

209

1303

1.63

9.90

1.6

1.8

2.90

5.00

mg/l

2.67

151

964

Testicular hypofunction

484

2.07

9.86

1.9

4.31

5.20

mg/l

0.18

362

Malignant neoplasm

1541

10712

0.84

9.85

1.6

1.7

4.05

4.29

mg/l

0.38

1217

7988

Polyuria

391

2778

1.42

9.84

1.8

1.7

4.30

4.59

mg/l

0.15

296

2057

Major coronary heart disease event excluding revascularizations

635

5459

0.76

9.81

2.2

1.5

6.45

3.81

mg/l

3.16

532

4064

Disorders of refraction and accommodation

734

5716

1.29

9.79

1.7

3.68

4.25

mg/l

0.75

549

4159

Postviral fatigue syndrome

185

2.92

9.78

2.0

1.8

3.99

3.26

mg/l

0.30

129

Myocardial infarction

467

4431

0.73

9.75

2.4

1.5

6.11

3.80

mg/l

2.21

395

3271

Status post-ami

139

1830

0.57

9.73

2.1

1.5

7.62

4.23

mg/l

0.95

115

1355

Anankastic personality disorder

137

772

1.84

9.73

1.4

1.8

2.99

4.26

mg/l

0.79

118

551

Erysipelas, including avohilmo

1124

10124

0.82

9.59

1.8

1.7

6.27

3.95

mg/l

3.83

951

7483

Myocardial infarction, strict

417

4066

0.72

9.58

2.4

1.5

5.85

3.84

mg/l

1.76

352

3003

Psychotic depression

153

890

1.76

9.57

1.9

1.8

3.00

4.15

mg/l

1.28

136

591

Other special examinations and investigations of persons without complaint or reported diagnosis

1533

6510

1.20

9.49

1.8

1.6

4.87

3.93

mg/l

1.82

1204

4490

Autism

507

2.04

9.45

1.5

1.8

3.23

3.82

mg/l

0.49

341

Malignant neoplasm

1547

10708

0.84

9.43

1.6

1.7

4.07

4.28

mg/l

0.32

1223

7984

Renal tubulo-interstitial diseases

1501

13000

0.84

9.42

2.0

1.7

6.42

4.11

mg/l

6.45

1232

9523

Mycoses, including avohilmo

2249

14883

1.16

9.41

1.7

4.10

4.24

mg/l

0.24

1669

10914

Monoamine oxidase A inhibitors

232

1503

1.57

9.40

1.8

1.7

3.68

4.51

mg/l

0.54

191

1049

Abdominal and pelvic pain

2400

10479

1.16

9.39

1.8

1.6

4.73

3.99

mg/l

1.52

1871

7433

Other and unspecified mood [affective] disorders

220

1413

1.59

9.38

1.6

1.7

4.33

4.59

mg/l

0.14

178

945

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1181

9741

1.22

9.38

1.8

1.7

5.46

4.28

mg/l

2.23

974

7250

Cardiovascular diseases

1933

8792

1.17

9.38

2.1

1.4

4.64

3.54

mg/l

2.42

1492

5927

Diseases of external ear

734

5768

1.28

9.36

1.6

1.7

4.35

4.43

mg/l

0.05

567

4267

Endometriosis of ovary

406

2760

1.40

9.34

1.7

3.90

4.54

mg/l

0.70

287

2041

Other inflammation of eyelid, including avohilmo

1196

9916

1.22

9.34

1.7

3.54

4.26

mg/l

1.70

885

7210

Allergic asthma (mode)

659

4994

1.30

9.27

1.6

1.4

4.47

3.47

mg/l

2.04

502

3396

Hyperplasia of prostate

555

2339

1.35

9.25

1.7

1.8

4.76

5.14

mg/l

0.19

414

1756

Bacterial infection, other or unspecified

642

6967

0.77

9.24

1.9

1.7

6.97

4.08

mg/l

4.36

537

5137

Allergic asthma (mode), excluding more controls

659

4999

1.30

9.20

1.6

1.4

4.47

3.41

mg/l

2.22

502

3384

Other/unspecified seropositive rheumatoid arthritis

240

3595

0.66

9.14

1.7

1.8

9.28

4.24

mg/l

2.93

198

2701

Paracetamol or NSAID medication

412

1482

1.42

9.10

1.8

1.5

3.72

3.99

mg/l

0.19

297

868

Haemorrhoids and perianal venous thrombosis

655

5054

1.30

9.09

1.7

4.13

4.42

mg/l

0.23

500

3697

Acute alcohol intoxication, ICD10

230

3464

0.66

9.06

1.6

1.7

5.60

4.42

mg/l

0.93

202

2526

Adenomyosis (Endometriosis of uterus)

281

1908

1.49

9.05

1.5

1.7

3.96

4.44

mg/l

0.37

219

1432

Symptoms and signs involving the digestive system and abdomen

2398

10479

1.15

9.03

1.8

1.6

4.84

3.99

mg/l

1.85

1876

7433

860

9508

0.80

8.99

1.7

5.31

4.31

mg/l

1.79

747

6898

Autism spe

496

2.02

8.98

1.6

1.8

3.32

3.96

mg/l

0.51

334

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

550

4196

1.33

8.97

1.8

1.6

3.75

4.10

mg/l

0.45

415

3020

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

238

3554

0.66

8.94

1.7

9.09

4.22

mg/l

2.78

197

2671

Malignant neoplasm, including Hilmo

1625

11080

0.85

8.85

1.7

4.31

4.27

mg/l

0.05

1273

8240

Malignant neoplasm, wide definition

1623

11061

0.85

8.85

1.7

4.28

4.27

mg/l

0.01

1270

8228

Solid cancers

1512

10423

0.85

8.72

1.6

1.7

3.89

4.28

mg/l

0.77

1188

7801

Asthma and allergy, excluding more controls

395

2843

1.39

8.70

1.5

1.4

4.15

3.47

mg/l

0.81

294

1889

Biguanides

1719

12075

0.85

8.68

1.9

1.7

5.27

4.13

mg/l

4.18

1547

8772

Disorders of eyelid, lacrimal system and orbit

1952

12381

1.16

8.66

1.8

1.7

3.94

4.43

mg/l

1.10

1521

9183

Diaphragmatic hernia

611

4739

1.30

8.66

1.8

1.7

5.64

4.11

mg/l

1.54

502

3567

Gastrointestinal diseases

1688

7215

1.18

8.65

1.7

1.6

4.92

3.71

mg/l

2.19

1303

4900

Peripheral arterial reconstruction

1255

0.45

8.65

2.0

1.6

10.54

5.31

mg/l

1.03

964

Asthma and allergy

395

2845

1.39

8.65

1.5

1.4

4.15

3.53

mg/l

0.72

294

1899

L04AX Other immunosuppressants

891

10925

0.81

8.64

3.6

1.6

7.42

4.07

mg/l

5.56

746

8069

Irregular menses

1441

9172

1.19

8.57

1.8

1.6

4.36

3.98

mg/l

0.45

1126

6661

Other or ill-defined heart diseases

125

709

1.80

8.57

9.6

1.4

3.05

5.49

mg/l

1.45

116

511

Certain infectious and parasitic diseases, including avohilmo

1802

7745

1.17

8.54

1.8

1.6

4.88

3.89

mg/l

1.66

1375

5454

L04AD Calcineurin inhibitors

254

1718

1.51

8.51

4.5

1.7

17.97

3.98

mg/l

9.73

239

1255

Organic, including symptomatic, mental disorders

419

3981

0.74

8.50

1.6

1.7

6.54

4.55

mg/l

1.39

342

3007

Retinal breaks without detachment

311

2184

1.44

8.49

2.0

1.7

4.17

4.36

mg/l

0.08

234

1645

Candidiasis, including avohilmo

722

5738

1.27

8.49

1.8

1.7

4.54

4.23

mg/l

0.29

548

4201

927

9836

0.81

8.41

1.7

5.34

4.31

mg/l

1.93

804

7134

Mixed and other personality disorders

232

1547

1.53

8.41

1.7

1.8

3.71

4.25

mg/l

0.47

203

1107

Thyroiditis, ILD-related definition

299

2094

1.45

8.38

1.9

1.7

3.99

4.17

mg/l

0.11

237

1533

Other heart diseases

1324

7242

1.20

8.35

3.7

1.4

4.85

3.50

mg/l

3.69

1079

5015

Visual disturbances

1030

8515

1.22

8.32

1.8

1.7

4.13

4.28

mg/l

0.15

808

6255

STROKE

838

6953

0.81

8.23

1.8

1.5

5.04

3.69

mg/l

2.10

666

5090

Spirochaetal infections, other/unspecified

184

1169

1.60

8.22

1.9

1.7

3.52

4.72

mg/l

0.75

134

876

Diseases of pulp and periapical tissues, including avohilmo

2071

12259

0.87

8.17

1.8

1.6

5.03

3.99

mg/l

2.25

1670

8665

Oter anti-inflammatory and antirheumatic agents, non-steroids

324

1245

1.44

8.12

1.8

4.17

4.99

mg/l

0.59

267

858

Asthma, hospital admissions , main diagnosis only

1930

14617

1.15

8.11

1.8

1.7

5.55

4.05

mg/l

5.00

1517

10642

Fibromyalgia

265

1828

1.48

8.10

1.6

1.7

5.42

4.33

mg/l

0.81

237

1297

Other disorders starting during childhood or adolecense, excluding more controls

132

738

1.75

8.08

1.5

1.6

4.55

3.44

mg/l

0.85

448

General symptoms and signs

2692

11946

1.13

8.05

1.9

1.6

4.82

3.95

mg/l

2.97

2128

8467

Liquid cancers

259

3528

0.69

8.02

1.4

1.7

6.48

4.80

mg/l

0.90

213

2609

Any event in cancer register

1817

12219

0.86

8.01

1.6

1.7

4.28

4.27

mg/l

0.01

1404

8992

Anxious personality disorder

385

2.10

8.00

1.5

2.0

2.80

3.39

mg/l

0.50

270

Bleeding

1229

10207

0.84

7.94

1.7

5.10

4.37

mg/l

0.77

992

7597

Presbyopia

205

1349

1.55

7.91

1.8

1.7

4.19

4.46

mg/l

0.08

148

1016

Seropositive rheumatoid arthritis, wide

253

3644

0.69

7.91

2.1

1.7

8.95

4.23

mg/l

2.88

210

2733

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2177

14895

1.14

7.87

1.9

1.6

4.28

4.23

mg/l

0.06

1666

10882

Dementia, including avohilmo

298

2860

0.71

7.84

1.5

1.7

6.16

4.72

mg/l

0.78

235

2167

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1269

10534

1.19

7.83

1.8

1.7

5.46

4.27

mg/l

2.43

1045

7800

Visual disturbances and blindness

1081

9021

1.20

7.83

1.9

1.7

4.16

4.32

mg/l

0.17

852

6639

Diseases of the skin and subcutaneous tissue

2417

10693

1.14

7.81

1.8

1.6

5.07

3.92

mg/l

2.70

1837

7619

Ovarian cyst

847

3923

1.25

7.80

1.5

1.6

3.87

4.45

mg/l

1.08

647

2838

Menorrhagia

772

3453

1.26

7.72

1.7

3.78

4.49

mg/l

1.28

589

2527

Amiodarone users

145

882

1.67

7.71

8.4

1.6

6.88

5.46

mg/l

0.49

137

665

Actinic keratosis

443

3035

1.33

7.68

1.8

1.7

5.20

4.71

mg/l

0.23

338

2316

Any dementia

207

2143

0.66

7.66

1.5

1.6

7.55

4.62

mg/l

1.29

161

1643

Mouth breathing

800

6497

1.24

7.65

1.7

1.8

4.03

4.43

mg/l

0.52

644

4825

Alcohol dependence

295

4110

0.71

7.63

1.6

1.8

5.37

4.54

mg/l

0.59

271

2979

Dissociative [conversion] disorders

118

687

1.77

7.55

1.5

1.7

3.15

4.26

mg/l

0.57

102

455

Excluding asthma or asthma-COPD overlap

1997

8735

1.15

7.53

2.1

1.4

5.14

3.47

mg/l

4.22

1556

6116

Caries of dentine, including avohilmo

1434

8562

0.85

7.52

1.8

1.6

5.22

3.78

mg/l

2.19

1105

6075

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1692

11385

0.86

7.45

2.0

1.6

6.56

3.71

mg/l

10.00

1401

8115

1692

11385

0.86

7.45

2.0

1.6

6.56

3.71

mg/l

10.00

1401

8115

Disorders of other endocrine glands

970

7934

1.21

7.45

1.7

4.73

4.13

mg/l

0.85

766

5768

Unspecified urinary incontinence

169

1078

1.59

7.45

1.6

1.7

4.16

4.32

mg/l

0.08

141

817

Solid cancers, including Hilmo

1601

10779

0.86

7.43

1.7

4.04

4.29

mg/l

0.40

1250

8038

Other degenerative diseases of the nervous system

280

2868

0.71

7.42

1.6

5.68

4.20

mg/l

0.87

209

2001

Other disorders of skin and subcutaneous tissue

1495

10862

1.17

7.38

1.7

5.21

4.26

mg/l

1.60

1202

8085

Abnormal results of function studies

200

1329

1.53

7.36

2.0

1.8

4.47

4.49

mg/l

0.01

162

985

Periapical abscess

729

8969

0.81

7.35

1.6

1.7

4.96

4.33

mg/l

0.75

590

6676

Cardiomyopathies, Primary/intrinsic

196

1295

1.53

7.34

4.9

1.5

8.97

5.23

mg/l

1.93

178

939

ILD differential diagnosis

1987

8707

1.15

7.32

2.1

1.4

5.13

3.48

mg/l

4.14

1546

6107

Psoriasis

358

4799

0.74

7.26

1.8

1.7

5.67

4.37

mg/l

0.98

302

3545

COPD differential diagnosis

1986

8710

1.15

7.24

2.1

1.4

5.12

3.48

mg/l

4.10

1545

6108

Other problems related to primary support group, including family circumstances

319

2263

1.39

7.13

1.8

1.7

4.87

4.32

mg/l

0.39

269

1626

Infections with a predominantly sexual mode of transmission, including avohilmo

1179

9160

1.19

7.11

1.6

1.7

3.64

4.11

mg/l

0.93

886

6510

Diseases of the musculoskeletal system and connective tissue

1514

6528

1.17

7.11

1.8

1.6

4.38

3.78

mg/l

1.20

1164

4357

364

2711

1.36

7.11

2.6

1.6

5.17

3.89

mg/l

1.21

292

1927

Insulin, intermediate and long-acting

720

8527

0.81

7.09

1.8

1.7

5.40

4.43

mg/l

1.40

670

6246

Other specified and unspecified personality disorders

242

1687

1.46

7.07

1.9

1.8

4.41

4.39

mg/l

0.01

220

1219

Dementia

276

2639

0.71

7.05

1.5

1.6

6.51

4.66

mg/l

0.95

216

2000

Other (not insulin) diabetes medications

1832

12260

0.87

7.05

2.0

1.7

5.54

4.08

mg/l

5.81

1655

8828

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

119

1955

0.60

7.04

1.4

1.7

7.21

4.65

mg/l

0.80

1444

Chronic apical periodontitis

2246

14182

0.88

7.04

1.8

1.7

5.12

4.05

mg/l

2.58

1834

10217

Oxicams

390

1645

1.36

6.99

1.6

1.8

4.76

4.72

mg/l

0.01

310

1086

Seropositive rheumatoid arthritis, strict definition

137

2171

0.62

6.98

1.5

1.7

9.56

4.09

mg/l

2.36

107

1631

Benign neoplasms

2451

11869

1.13

6.98

1.6

1.7

4.05

4.26

mg/l

0.34

1827

8614

Skin changes due to chronic exposure to nonionizing radiation

460

3199

1.31

6.98

1.8

1.7

5.09

4.65

mg/l

0.21

351

2431

Other and unspecified disorders of skin and subcutaneous tissue

132

808

1.67

6.96

1.6

1.8

5.56

4.57

mg/l

0.29

107

598

1043

8719

1.19

6.93

1.8

1.7

5.90

3.92

mg/l

4.76

855

6285

Methotrexate

134

2128

0.62

6.90

1.6

1.5

7.87

4.02

mg/l

1.41

110

1559

Wide developmental disorders

108

628

1.77

6.88

1.5

1.7

3.11

3.80

mg/l

0.68

429

Infections with a predominantly sexual mode of transmission

872

7233

1.21

6.83

1.6

1.7

3.49

4.13

mg/l

1.27

679

5182

Seropositive rheumatoid arthritis

253

3526

0.71

6.83

2.1

1.7

8.95

3.86

mg/l

3.26

210

2520

Other dorsopathies, not elsewhere classified

2501

11586

1.13

6.81

1.6

1.7

4.33

3.99

mg/l

0.67

1934

8246

Any dementia, excluding more controls

203

2042

0.68

6.79

1.5

1.6

7.21

4.86

mg/l

0.94

157

1514

Mental and behavioural disorders due to alcohol

768

8875

0.82

6.76

1.7

5.23

4.29

mg/l

1.55

671

6429

Other and unspecified polyneuropathies, also in other diseases

292

2116

1.39

6.73

1.7

4.99

4.82

mg/l

0.06

239

1601

Speech and linguistic disorders, excluding more controls

196

1239

1.51

6.71

1.6

5.29

4.07

mg/l

0.70

157

761

Factors influencing health status and contact with health services

672

2704

1.26

6.66

1.9

1.4

5.18

3.48

mg/l

1.06

492

1849

Low back pain

1906

11335

1.14

6.63

1.7

5.00

4.00

mg/l

2.60

1519

8099

Failed induction of labour

219

1523

1.48

6.61

1.7

3.55

4.57

mg/l

1.21

185

1069

Sulfasalazine

392

5116

0.76

6.60

1.6

1.5

5.22

3.86

mg/l

1.79

319

3707

Desensitization to allergens

174

1155

1.54

6.60

1.4

1.8

3.66

4.75

mg/l

0.78

120

799

Other (seronegative) rheumatoid arthritis, wide

170

2542

0.66

6.59

1.6

1.7

7.62

4.15

mg/l

1.44

136

1911

Other disorders of veins

849

6945

1.21

6.58

1.8

1.7

3.66

4.24

mg/l

0.91

670

5248

ILD medications: prednisolone, methylprednisolone, prednisone

2643

13188

1.12

6.50

2.7

1.4

5.69

3.70

mg/l

9.91

2208

9356

Inflammatory bowel disease, strict (require KELA)

342

4532

0.75

6.49

1.6

1.7

3.98

4.24

mg/l

0.25

260

3291

Other diseases of pleura

409

4612

0.77

6.49

2.2

1.7

11.99

4.64

mg/l

7.07

350

3454

Diseases of pulp and periapical tissues and dental caries

1175

7053

0.85

6.41

1.8

1.6

5.19

3.79

mg/l

1.67

906

4978

Dental caries, including avohilmo

1305

7754

0.86

6.38

1.8

1.6

5.12

3.82

mg/l

1.68

1014

5520

Postmenopausal bleeding

438

1756

1.32

6.33

1.8

3.71

4.98

mg/l

2.37

344

1376

Cardiomyopathy (excluding other)

198

1356

1.48

6.29

4.9

1.5

8.98

5.26

mg/l

1.95

180

991

Retinal detachments and breaks

566

4535

1.26

6.29

1.9

1.7

4.68

4.62

mg/l

0.03

430

3411

IBD patients in KELA-register

342

4510

0.75

6.28

1.6

1.7

3.98

4.19

mg/l

0.19

260

3266

Polyneuropathies and other disorders of the peripheral nervous system

336

2519

1.35

6.26

1.6

1.7

5.25

4.84

mg/l

0.15

277

1902

Temporomandibular joint disorders, including avohilmo

1248

10433

1.17

6.23

1.7

3.28

4.17

mg/l

4.55

909

7563

Gluteal tendinitis

111

671

1.69

6.23

1.5

1.8

3.10

4.40

mg/l

0.74

492

malignant neoplasm of female genital organs

129

1971

0.63

6.21

1.5

1.7

6.10

4.20

mg/l

0.81

102

1476

Other pulmonary diagnosis

1971

8735

1.14

6.20

1.8

1.4

5.20

3.47

mg/l

4.41

1529

6116

Endometriosis of intestine

302

2.08

6.19

2.0

1.9

4.21

3.54

mg/l

0.32

206

malignant neoplasm of female genital organs, including Hilmo

158

2254

0.66

6.19

1.5

1.7

6.00

4.19

mg/l

0.92

125

1681

Colorectal cancer, including Hilmo

217

2860

0.70

6.18

1.3

1.7

4.86

4.89

mg/l

0.01

186

2139

Non-rheumatic valve diseases

553

4917

0.80

6.18

2.1

1.4

5.36

4.46

mg/l

0.63

410

3580

Type 2 diabetes, wide definition

1252

9144

0.86

6.15

2.1

1.6

5.72

4.12

mg/l

4.04

1152

6646

Paroxysmal tachycardia

550

3654

1.26

6.13

4.0

1.4

4.89

3.58

mg/l

1.73

436

2511

Dorsopathies

2550

11602

1.12

6.13

1.6

1.7

4.47

4.00

mg/l

1.04

1970

8256

Diabetes medication

2083

13632

0.89

6.11

2.0

1.6

5.48

4.00

mg/l

6.95

1896

9702

Undetermined asthma

282

2067

1.38

6.11

1.8

1.4

6.19

3.53

mg/l

2.65

240

1444

Soft tissue disorders related to use, overuse and pressure

550

4412

1.26

6.10

2.0

1.7

4.44

4.45

mg/l

0.01

458

3187

Cerebrovascular diseases (FINNGEN)

496

4373

0.79

6.08

1.8

1.4

4.53

3.51

mg/l

1.12

398

3060

Persons encountering health services in circumstances related to reproduction

1427

8322

1.16

6.08

1.7

4.45

4.20

mg/l

0.28

1024

6196

Disorders of vitreous body

888

7105

1.19

6.03

1.7

4.31

4.53

mg/l

0.22

677

5402

Undetermined asthma, excluding more controls

282

2072

1.38

6.02

1.8

1.4

6.19

3.52

mg/l

2.66

240

1437

Gestational diabetes (for exclusion)

1192

7056

1.17

6.02

1.8

1.6

4.17

3.95

mg/l

0.40

967

5020

Intentional self-harm by unspecified means

245

2.19

6.00

1.8

4.33

4.14

mg/l

0.07

170

Valvular heart disease excluding rheumatic fever

559

4946

0.80

5.95

2.1

1.4

5.34

4.45

mg/l

0.63

416

3604

Etanercept

1164

0.53

5.95

1.4

1.8

5.11

4.36

mg/l

0.32

848

Procreative management

850

5875

1.20

5.90

1.7

4.63

4.11

mg/l

0.50

593

4358

Convalescence

127

806

1.61

5.88

1.5

1.6

3.71

4.25

mg/l

0.20

105

585

Other joint disorders

2296

10727

1.12

5.88

1.7

1.6

4.39

4.00

mg/l

0.82

1781

7520

Nonischemic cardiomyopathy

160

1066

1.52

5.85

5.5

1.7

6.51

4.70

mg/l

0.73

147

791

Adalimumab

125

1933

0.64

5.85

1.7

8.09

4.33

mg/l

1.57

105

1410

Other diseases of urinary system

2292

11536

1.12

5.83

1.7

4.58

4.25

mg/l

0.57

1753

8434

Fissure and fistula of anal and rectal regions

499

3982

1.26

5.83

1.7

3.93

4.22

mg/l

0.22

391

2898

Dilated cardiomyopathy

176

1198

1.49

5.82

4.8

1.7

8.51

5.06

mg/l

1.73

160

899

Fracture of femur

174

2281

0.68

5.81

1.7

5.19

4.68

mg/l

0.24

149

1724

501

3588

1.26

5.80

1.8

1.7

5.26

4.69

mg/l

0.29

385

2715

Bronchitis

2585

14003

1.11

5.79

1.8

1.7

5.31

3.97

mg/l

5.04

2012

10151

Oligomenorrhoea

101

609

1.70

5.78

2.1

1.8

3.75

3.97

mg/l

0.12

432

All chronic kidney diseases

712

6837

0.83

5.78

2.1

1.7

6.91

4.18

mg/l

4.51

620

5011

Calcific aortic valvular stenosis, including rheumatic fever

159

2257

0.67

5.77

1.7

4.35

5.25

mg/l

0.55

127

1723

Hernia of abdominal wall, postoperative

373

2854

1.31

5.76

1.8

1.6

6.41

3.80

mg/l

1.18

323

2030

Disorders of vitreous body and globe

906

7249

1.19

5.76

1.8

4.28

4.52

mg/l

0.23

692

5518

Calcific aortic valvular stenosis, diagnosis (helper)

158

2247

0.67

5.76

1.7

4.38

5.25

mg/l

0.51

126

1714

Operations 2 for CAVS

158

2247

0.67

5.76

1.7

4.38

5.25

mg/l

0.51

126

1714

Other and unspecified disorders of vitreous body

734

5970

1.21

5.70

1.7

4.36

4.47

mg/l

0.08

545

4567

Alcohol abuse, main dg

184

2628

0.69

5.69

1.6

1.7

5.41

4.69

mg/l

0.38

166

1912

Other Crohn's disease

1263

0.56

5.68

1.3

1.8

3.99

4.57

mg/l

0.23

905

Nonalcoholic fatty liver disease

231

1664

1.41

5.68

1.8

4.14

4.45

mg/l

0.24

208

1244

Other noninflammatory disorders of vulva and perineum

230

1656

1.41

5.66

1.7

3.76

4.64

mg/l

0.64

160

1202

Colorectal cancer

190

2590

0.70

5.63

1.3

1.7

4.13

4.92

mg/l

0.50

163

1936

Superficial injury of lower leg

594

4854

1.23

5.61

1.8

1.7

3.90

4.44

mg/l

0.94

476

3503

Pain in limb

1956

11087

1.12

5.59

1.8

1.6

4.48

4.22

mg/l

0.45

1592

7818

Hyperhidrosis

585

1.70

5.57

1.7

1.6

4.08

4.68

mg/l

0.19

395

Calcific aortic valvular stenosis

160

2253

0.68

5.55

1.7

4.51

5.24

mg/l

0.41

128

1717

Calcific aortic valvular stenosis, operated

160

2253

0.68

5.55

1.7

4.51

5.24

mg/l

0.41

128

1717

Exclusions for E4_PCOS_CONSORTIUM

1849

10272

1.13

5.51

1.7

3.90

4.14

mg/l

0.46

1431

7527

Other disorders of eyelid

699

5478

1.21

5.48

1.7

3.02

4.53

mg/l

5.95

548

4148

Invasive ventilation

915

0.50

5.48

2.2

1.7

5.58

4.83

mg/l

0.14

671

Diseases of arteries, arterioles and capillaries (FINNGEN)

326

2938

0.76

5.48

1.8

1.4

6.32

3.34

mg/l

2.94

266

2038

Alcohol use disorder, Swedish definition

828

8883

0.84

5.46

1.7

5.42

4.35

mg/l

1.81

722

6482

Asthma (diagnoses ohter than nonallergic)

2015

14592

1.12

5.43

1.9

1.6

5.67

4.03

mg/l

4.44

1641

10574

Migraine with aura and triptan purchases

468

3749

1.26

5.40

1.9

1.7

4.15

4.25

mg/l

0.08

371

2682

Pain associated with micturition

238

1737

1.39

5.40

1.6

1.7

4.10

4.24

mg/l

0.08

184

1280

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

778

6554

1.20

5.39

1.6

1.7

4.72

4.15

mg/l

1.07

663

4671

Cardiovascular diseases (excluding rheumatic etc)

1918

9797

1.13

5.38

2.3

1.4

4.83

3.51

mg/l

3.36

1552

6673

Implicit viral Sepsis, including avohilmo

537

4351

1.24

5.37

2.4

1.6

7.74

4.14

mg/l

4.42

458

3150

Candidiasis

310

2360

1.33

5.33

1.7

5.95

4.34

mg/l

0.98

230

1737

Non-selective monoamine reuptake inhibitors

646

5130

1.21

5.31

1.7

1.8

5.17

4.33

mg/l

0.83

550

3727

Hypertensive heart and/or renal disease

213

2150

0.72

5.26

1.7

6.29

4.13

mg/l

0.91

184

1543

Certain infectious and parasitic diseases

2409

10908

1.11

5.24

1.8

1.6

5.08

3.80

mg/l

3.35

1861

7756

Emotional disorders starting during childhood or adolecense, excluding more controls

120

749

1.58

5.23

1.5

1.6

5.09

3.52

mg/l

1.29

447

Other diseases of anus and rectum

528

4277

1.24

5.22

1.9

1.7

4.10

4.44

mg/l

0.28

426

3138

Arthropod-borne viral fevers and viral haemorrhagic fevers

1296

0.59

5.19

1.2

1.8

5.22

4.68

mg/l

0.12

971

Other inflammation of eyelid

284

2145

1.34

5.16

1.6

1.7

4.56

4.17

mg/l

0.16

221

1587

Bacterial Sepsis

535

5402

0.81

5.10

2.1

1.7

9.71

4.12

mg/l

7.19

468

3987

Abnormal findings on examination of blood, without diagnosis

797

6109

1.19

5.05

1.8

1.7

6.90

4.48

mg/l

3.60

658

4531

Mycoses

560

4605

1.22

5.02

1.7

5.50

4.40

mg/l

1.02

427

3392

Pleural effusion

1411

0.61

5.00

2.8

1.7

9.39

4.61

mg/l

1.39

1052

Malaise and fatigue

1073

7324

1.16

4.96

1.9

1.6

4.67

4.00

mg/l

1.01

846

5253

Schizophrenia or delusion

500

6113

0.81

4.94

1.7

4.59

4.17

mg/l

0.58

426

4426

Papulosquamous disorders

552

6684

0.82

4.92

1.9

1.7

5.96

4.29

mg/l

1.89

456

4987

Injuries to the ankle and foot

1834

14066

1.12

4.92

1.8

1.7

4.50

4.10

mg/l

0.82

1463

10163

Other skin changes

339

2640

1.29

4.92

1.7

5.79

4.72

mg/l

0.49

262

1982

Arthropathic psoriasis

118

1774

0.66

4.87

1.5

1.8

4.20

4.31

mg/l

0.07

1328

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

114

1727

0.65

4.85

1.6

1.8

6.04

5.12

mg/l

0.58

103

1290

Malignant neoplasm of pancreas, including Hilmo

810

0.50

4.81

1.5

1.7

9.44

5.17

mg/l

0.57

603

Dysplasia of cervi uteri

599

3490

1.22

4.80

1.8

1.7

3.75

4.47

mg/l

1.09

428

2527

Polycystic ovarian syndrome

204

1491

1.40

4.77

1.7

1.6

4.85

3.79

mg/l

1.34

166

1034

Other general symptoms and signs

135

904

1.51

4.76

1.6

5.81

4.70

mg/l

0.25

101

623

Blepharochalasis

446

3605

1.24

4.72

1.7

2.57

4.49

mg/l

7.15

353

2756

Early onset COPD

220

2956

0.74

4.71

1.8

9.54

4.42

mg/l

3.54

192

2220

Ulcerative colitis, NAS

172

2395

0.71

4.68

1.8

1.7

5.29

4.13

mg/l

0.55

137

1745

Nasal polyp

330

2581

1.29

4.66

1.6

1.7

5.16

4.69

mg/l

0.23

268

1879

Opioids

2470

11622

1.10

4.66

1.7

1.6

5.03

3.68

mg/l

4.30

2041

8091

Schizophrenia, schizotypal and delusional disorders

504

6114

0.82

4.63

1.7

4.57

4.18

mg/l

0.54

428

4426

Explicit Sepsis, including avohilmo

562

6122

0.83

4.61

2.0

1.6

7.83

4.16

mg/l

4.16

474

4480

Primary_lymphoid and hematopoietic malignant neoplasms

198

2694

0.73

4.60

1.4

1.7

6.34

4.84

mg/l

0.64

157

2018

Psoriasis vulgaris

221

2952

0.74

4.58

1.6

1.7

7.22

4.61

mg/l

1.38

182

2178

Secondary uncertain malignant neoplasm

1488

0.64

4.57

1.4

1.7

8.32

4.76

mg/l

0.69

1104

Pure hypercholesterolaemia

1470

8295

1.13

4.57

1.9

1.7

4.01

4.48

mg/l

0.82

1217

6141

Intestinal infectious diseases

2184

14758

1.10

4.56

1.8

1.6

5.37

4.04

mg/l

3.05

1732

10685

Procedures for purposes other than remedying health state

403

1.76

4.55

1.5

1.7

2.45

4.71

mg/l

0.88

295

Disorders of thyroid, IBD co-morbidities

494

2764

1.23

4.53

2.4

1.5

4.67

3.18

mg/l

2.20

400

1726

Seronegative rheumatoid arthritis

108

1627

0.66

4.52

1.7

6.44

4.27

mg/l

0.84

1152

Disorders of psychological development

316

2289

1.29

4.52

1.5

1.6

4.63

3.98

mg/l

0.54

257

1550

Transport accidents

1166

8532

1.14

4.51

1.6

1.7

4.18

4.20

mg/l

0.02

876

6019

MS-disease / Multiple Sclerosis

1404

0.63

4.51

1.6

1.8

4.79

4.27

mg/l

0.17

1027

Ischaemic heart disease, wide definition

1111

7798

0.87

4.50

2.1

1.7

6.33

4.23

mg/l

3.26

911

5880

Other and unspecified disorders of autonomic nervous system

3.12

4.50

1.3

1.9

5.37

3.60

mg/l

0.21

Colorectal adenocarcinoma

150

2099

0.70

4.50

1.3

1.7

4.25

4.90

mg/l

0.30

128

1570

Degenerative diseases of the nervous system

199

1948

0.73

4.50

1.5

1.6

6.65

4.88

mg/l

0.70

156

1501

Anogenital herpesviral [herpes simplex] infection, including avohilmo

331

2609

1.29

4.49

1.6

1.7

3.91

4.33

mg/l

0.31

243

1864

Sequelae of cerebrovascular disease

307

3353

0.78

4.49

1.7

4.37

5.01

mg/l

0.39

242

2516

Rosacea

288

2230

1.31

4.46

1.7

1.8

3.99

4.19

mg/l

0.15

233

1645

Adverse effects, not elsewhere classified

463

3788

1.23

4.46

1.6

1.7

4.84

4.27

mg/l

0.49

356

2794

ILD medications: immunosuppressive drugs

1185

12143

0.88

4.45

3.4

1.4

8.65

3.64

mg/l

13.49

1003

8693

Urticaria

710

6039

1.18

4.45

1.7

4.53

4.19

mg/l

0.34

562

4402

Other disorders of skin and subcutaneous tissue, not elsewhere classified

244

1848

1.33

4.41

1.7

4.96

4.45

mg/l

0.26

202

1380

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1062

5849

1.15

4.40

1.6

4.00

4.03

mg/l

0.04

785

4165

Ascites

849

0.54

4.39

1.5

1.7

6.08

4.30

mg/l

0.76

628

Diseases of the respiratory system

1566

7008

1.12

4.38

1.8

1.6

4.99

3.40

mg/l

3.18

1199

4921

Psoriatic and enteropathic arthropathies

137

1958

0.69

4.38

1.7

1.8

3.99

4.14

mg/l

0.10

117

1378

Other disorders of fluid, electrolyte and acid-base balance

309

3700

0.78

4.37

2.3

1.7

5.34

4.64

mg/l

0.47

261

2723

Mental and behavioural disorders due to alcohol, excluding acute intoxication

653

7628

0.84

4.36

1.7

5.35

4.41

mg/l

1.30

575

5595

Other pleural conditions

887

0.55

4.35

1.7

5.90

4.95

mg/l

0.20

673

Other obstetric conditions, not elsewhere classified

1078

5959

1.15

4.35

1.7

1.6

3.99

4.01

mg/l

0.02

794

4250

Chronic gastritis

379

3039

1.25

4.34

1.8

1.7

5.58

4.43

mg/l

0.36

307

2254

L04AC Interleukin inhibitors

1195

0.61

4.33

1.4

1.8

6.05

4.58

mg/l

0.57

868

Herpesviral [herpes simplex] infections, including avohilmo

630

5321

1.19

4.33

1.7

3.78

4.13

mg/l

0.43

462

3909

Ulcerative ileocolitis

696

0.49

4.32

2.2

1.8

2.99

4.16

mg/l

0.94

513

Hypertensive diseases (excluding secondary)

1397

7230

1.13

4.30

1.9

1.4

5.80

3.47

mg/l

5.43

1219

5036

Other sexually transmitted chlamydial diseases

205

1525

1.37

4.30

1.5

1.7

3.29

4.13

mg/l

1.43

158

1058

Shoulder lesions

1601

8599

1.12

4.29

1.7

4.31

4.36

mg/l

0.04

1294

6233

Hypersomnia

221

2.03

4.29

1.6

1.8

2.84

3.55

mg/l

0.37

163

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1107

0.60

4.29

1.2

1.8

4.54

4.72

mg/l

0.04

825

Unspecified dementia

494

0.43

4.26

1.4

1.7

11.10

4.66

mg/l

0.79

410

All-cause Heart Failure

571

4739

0.83

4.25

3.5

1.6

7.26

4.49

mg/l

3.88

531

3525

Suggestive for eosinophilic asthma

172

1243

1.40

4.25

1.8

1.7

6.68

3.94

mg/l

1.28

145

912

Undefined dementia

507

0.43

4.24

1.4

1.8

11.10

5.48

mg/l

0.66

423

Impotence

540

1.61

4.24

1.8

2.35

5.14

mg/l

2.86

401

Asthma-related infections

1257

10884

1.13

4.23

1.9

1.7

6.35

4.05

mg/l

6.34

1047

7895

Asthma, hospital admission 2, infections

1257

10884

1.13

4.23

1.9

1.7

6.35

4.05

mg/l

6.34

1047

7895

Enlarged lymph nodes

329

2608

1.27

4.22

3.4

1.6

4.76

4.21

mg/l

0.27

261

1855

Septicaemia

485

5336

0.82

4.21

2.1

1.7

8.38

4.19

mg/l

4.24

418

3918

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1472

10240

1.12

4.19

1.8

1.7

3.72

4.29

mg/l

1.38

1056

7606

Psoriatic arthropathies, ICD10

112

1645

0.67

4.18

1.5

1.8

4.23

4.52

mg/l

0.17

1233

Coronary artery bypass grafting

164

1682

0.72

4.18

1.6

1.5

6.35

4.34

mg/l

0.73

135

1244

Crohn disease (strict definition, require KELA, min 2 HDR)

1159

0.61

4.18

1.4

1.8

3.66

4.58

mg/l

0.61

829

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1245

0.62

4.17

1.4

1.8

3.53

4.64

mg/l

0.87

896

Disorders of ocular muscles, binocular movement, accommodation and refraction

1148

10069

1.14

4.16

1.7

4.19

4.15

mg/l

0.04

861

7328

Contraceptive management

1077

6620

1.14

4.14

1.6

1.7

4.21

4.17

mg/l

0.03

817

5005

Explicit Sepsis

550

5959

0.84

4.09

2.0

1.6

7.89

4.18

mg/l

4.11

465

4369

Coronary atherosclerosis

838

6095

0.86

4.06

2.0

1.5

6.32

3.78

mg/l

3.40

686

4540

Nontraumatic intracranial haemmorrhage

144

2015

0.71

4.05

1.7

5.21

4.96

mg/l

0.06

114

1528

Urinary track infection

1620

7298

1.12

4.05

1.7

1.6

4.15

4.00

mg/l

0.24

1237

5313

Chronic pancreatitis

103

1529

0.67

4.05

1.5

1.8

5.44

4.31

mg/l

0.32

1130

Crohn disease (strict definition, require KELA)

1174

0.62

4.04

1.4

1.8

3.68

4.61

mg/l

0.63

840

Complications of medical and surgical care

1546

12514

1.11

4.02

1.9

1.7

5.21

4.21

mg/l

2.39

1276

9248

6-mercaptopurine

677

0.51

4.00

1.4

1.5

3.80

4.41

mg/l

0.19

483

Drug-induced neutropenia

962

0.58

4.00

1.8

7.24

4.48

mg/l

0.58

713

Other predominantly sexually transmitted diseases, not elsewhere classified

466

3865

1.22

3.99

1.6

1.7

3.52

4.18

mg/l

0.76

368

2768

Hypertensive Heart Disease

194

1967

0.74

3.99

1.7

6.28

4.28

mg/l

0.73

168

1411

Other and unspecified iron deficiency

596

5035

1.19

3.98

2.0

1.7

4.61

4.28

mg/l

0.30

485

3739

Malignant neoplasm of eye, brain and central nervous system

597

0.48

3.96

1.5

1.8

3.56

5.09

mg/l

0.57

428

Excessive earwax

1176

9465

1.13

3.94

1.8

1.7

4.84

4.34

mg/l

0.50

888

7047

Achilles tendinitis

215

1630

1.33

3.94

1.8

4.70

4.41

mg/l

0.09

176

1199

Speech therapy

293

3693

0.79

3.93

1.6

1.7

3.78

4.68

mg/l

0.83

223

2772

Erysipelas

786

7809

0.86

3.92

1.9

1.7

6.23

4.08

mg/l

3.53

681

5780

Cholelithiasis

1759

10882

1.11

3.92

1.9

1.7

5.52

4.12

mg/l

3.13

1497

8036

Malignant neoplasm of ovary, including Hilmo

817

0.56

3.91

1.6

1.7

8.00

4.07

mg/l

0.63

618

Crohn's disease of large intestine

890

0.57

3.89

1.5

1.8

4.83

4.54

mg/l

0.08

651

Other psoriatic arthropathies

111

1609

0.68

3.89

1.5

1.8

4.23

4.56

mg/l

0.19

1206

Urticaria and erythema

832

7246

1.15

3.88

1.8

1.7

4.39

4.18

mg/l

0.22

660

5299

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

904

0.58

3.88

1.8

1.9

4.26

4.68

mg/l

0.15

655

Other disorders of penis

147

1050

1.41

3.88

1.9

1.8

4.41

4.91

mg/l

0.16

120

762

Focal epilepsy, mode (most common among epilepsy diagnosis)

209

2741

0.76

3.88

1.6

1.7

6.00

4.50

mg/l

0.66

166

2006

2621

12245

1.09

3.87

1.8

1.6

5.23

3.86

mg/l

5.29

2039

8781

Focal epilepsy

247

3169

0.77

3.87

1.6

1.7

6.73

4.47

mg/l

1.09

198

2326

Crohn's disease NAS

1088

0.62

3.87

1.5

1.9

4.74

4.51

mg/l

0.07

790

Agranulocytosis

105

1536

0.68

3.86

1.9

1.7

10.44

4.42

mg/l

1.47

1155

Endometriosis ASRM stages 1,2

448

3715

1.22

3.86

1.6

1.7

4.07

4.03

mg/l

0.04

338

2753

Diseases of middle ear and mastoid

1429

10495

1.12

3.84

1.6

1.7

4.54

4.08

mg/l

0.67

1044

7505

Other diseases of liver

360

2919

1.24

3.83

1.7

1.8

4.96

4.47

mg/l

0.33

315

2170

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

261

3319

0.78

3.82

1.6

1.8

4.10

4.37

mg/l

0.19

198

2410

Demyelinating diseases of the central nervous system

113

1624

0.69

3.81

1.7

4.20

4.53

mg/l

0.13

1192

Voice disturbances

504

4225

1.20

3.81

1.6

1.7

3.40

4.52

mg/l

2.41

373

3194

Other functional intestinal disorders

880

6989

1.15

3.81

1.6

1.7

3.89

4.34

mg/l

0.81

692

5141

Malignant neoplasm of brain

492

0.44

3.80

1.4

1.9

2.55

4.24

mg/l

1.29

359

Contact with and exposure to communicable diseases

653

7560

0.85

3.80

1.5

1.6

3.79

4.13

mg/l

0.31

446

5394

Testicular dysfunction, other/unspecified

2.95

3.79

1.2

1.7

1.56

3.43

mg/l

0.89

Pustular psoriasis

690

0.53

3.76

1.5

1.8

4.48

4.59

mg/l

0.03

510

Ethmoidectomy

270

2125

1.28

3.75

1.6

1.8

4.12

4.17

mg/l

0.03

220

1572

Colonic or urogenital fistula

516

4343

1.20

3.74

1.7

4.03

4.36

mg/l

0.26

404

3221

Dorsalgia

2372

11562

1.09

3.72

1.6

1.7

4.51

3.99

mg/l

1.30

1865

8238

Disorders of lipoprotein metabolism and other lipidaemias

1667

9182

1.11

3.72

2.0

1.7

4.11

4.39

mg/l

0.44

1401

6807

Localized swelling, mass and lump of skin and subcutaneous tissue

621

5311

1.18

3.72

1.8

1.7

4.50

4.39

mg/l

0.07

464

3941

Malignant neoplasm of brain, including Hilmo

675

0.53

3.71

1.3

1.8

2.85

5.09

mg/l

1.38

489

Acute tubulo-interstitial nephritis

1027

9774

0.88

3.71

1.8

1.6

5.44

4.11

mg/l

2.53

813

7149

All kidney diseases

1963

14353

0.91

3.71

1.9

1.6

5.74

4.02

mg/l

5.87

1602

10445

Unspecific neurodegenerative disorder

255

2230

0.78

3.69

1.4

1.7

5.79

4.73

mg/l

0.47

199

1704

Female infertility, associated with anovulation

244

1904

1.30

3.68

1.7

4.79

4.15

mg/l

0.37

189

1319

Other/unspecified rheumatoid arthritis

1366

0.67

3.66

1.6

1.7

8.83

4.23

mg/l

1.07

1045

Gonarthrosis

1287

6503

1.12

3.64

1.7

4.84

4.19

mg/l

0.90

1076

4803

Cervicalgia

408

3370

1.22

3.64

1.8

1.7

3.98

4.28

mg/l

0.28

333

2451

Early onset COPD, excluding more controls

220

2838

0.77

3.64

1.8

1.5

9.54

3.59

mg/l

4.62

192

2023

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

147

1045

1.40

3.63

1.6

1.7

4.72

3.68

mg/l

0.86

109

700

Other and unspecified urticaria

445

3709

1.21

3.63

1.8

1.7

4.66

4.28

mg/l

0.29

361

2728

Other/unspecified enthesopathies of lower limb, excluding foot

164

1211

1.37

3.63

1.7

3.81

4.43

mg/l

0.40

124

875

Symptoms and signs involving speech and voice

597

5102

1.18

3.61

1.7

3.51

4.45

mg/l

2.14

451

3837

Mucosal proctocolitis

176

2336

0.75

3.61

1.7

4.84

4.19

mg/l

0.30

140

1694

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

684

5909

1.16

3.61

2.1

1.7

4.86

4.22

mg/l

0.67

543

4387

Malignant neoplasm of colon, including Hilmo

141

1929

0.72

3.60

1.4

1.7

5.19

4.88

mg/l

0.10

120

1446

Pustulosis palmaris et plantaris

639

0.52

3.57

1.4

1.8

3.94

4.66

mg/l

0.20

468

Psoriatic arthropathies

114

1616

0.70

3.56

1.5

1.7

4.28

4.10

mg/l

0.09

1138

Diabetes mellitus in pregnancy

1054

5948

1.13

3.54

1.7

1.6

4.38

3.94

mg/l

0.94

872

4199

Heartburn

228

1772

1.30

3.52

1.9

1.7

4.16

4.06

mg/l

0.05

185

1264

Other bacterial intestinal infections, including avohilmo

425

3537

1.21

3.51

1.7

4.79

4.20

mg/l

0.42

332

2602

Disorders of skin appendages

1197

10686

1.12

3.49

1.6

1.7

4.39

4.14

mg/l

0.40

944

7734

Endometriosis ASRM stages 3,4

504

4266

1.19

3.48

1.7

3.80

4.09

mg/l

0.32

359

3192

Malignant neoplasm of rectum, including Hilmo

1243

0.66

3.46

1.3

1.7

4.53

5.02

mg/l

0.13

936

Focal epilepsy, strict definition

222

2842

0.78

3.46

1.6

1.7

6.81

4.44

mg/l

1.04

180

2081

Alcohol use disorder, ICD-based

617

7156

0.86

3.45

1.7

5.23

4.45

mg/l

0.96

544

5253

Missing teeth due to accident, extraction or parodontitis

890

8994

0.88

3.45

1.8

1.7

5.84

4.32

mg/l

1.50

750

6733

FESS (DNB20)

261

2070

1.27

3.44

1.6

1.7

4.04

4.16

mg/l

0.06

211

1536

Family history of certain disabilities and chronic diseases leading to disablement

139

1012

1.40

3.42

1.7

1.5

4.92

4.24

mg/l

0.27

104

700

Ulcerative colitis (strict definition, require KELA)

245

3092

0.79

3.42

1.6

1.7

4.17

4.31

mg/l

0.09

189

2242

Erosion of teeth , including avohilmo

656

5679

1.16

3.42

1.7

4.91

4.05

mg/l

0.45

490

4115

Amenorrhoea

190

1450

1.33

3.41

1.7

3.88

4.21

mg/l

0.29

142

1008

Combinations of oral blood glucose lowering drugs

314

3858

0.81

3.40

2.0

1.7

4.64

4.68

mg/l

0.02

282

2826

Pruritus

234

1835

1.29

3.39

1.6

1.7

4.80

3.83

mg/l

0.56

196

1357

Left bundle-branch block

113

793

1.44

3.37

4.5

1.5

4.65

5.09

mg/l

0.13

101

575

Accidents

1958

8992

1.09

3.37

1.7

4.63

4.18

mg/l

0.59

1496

6374

Lower back pain or/and sciatica

2504

14426

1.08

3.37

1.7

4.84

4.13

mg/l

1.96

2004

10464

Kela-code for behavioural disturbances in mental retardation

0.00

3.36

0.0

1.8

—

3.60

—

Disorder of lipoprotein metabolism, unspecified

170

1276

1.34

3.36

2.1

1.8

4.68

5.05

mg/l

0.11

148

940

Erectile dysfunction

580

1.51

3.36

2.9

1.6

9.57

4.55

mg/l

1.83

426

Eustachian salpingitis and obstruction

208

1611

1.31

3.36

1.7

1.8

3.14

4.31

mg/l

1.52

161

1157

Implicit bacterial Sepsis, including avohilmo

526

5130

0.85

3.35

2.2

1.7

9.45

4.19

mg/l

7.21

462

3789

Acne, including avohilmo

679

4770

1.16

3.34

1.6

3.99

4.11

mg/l

0.12

488

3200

Other condition

187

2432

0.76

3.33

1.6

1.7

6.97

4.51

mg/l

1.25

141

1774

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2312

13507

1.08

3.33

2.7

1.5

5.78

3.96

mg/l

6.82

1887

9816

Bruxism

332

1.71

3.33

1.5

1.8

3.76

3.13

mg/l

0.36

236

Diarrhoea and gastroenteritis of presumed infectious origin

1588

12926

1.10

3.33

1.9

1.6

5.33

4.03

mg/l

3.18

1283

9341

Other symptoms and signs involving the digestive system and abdomen

327

2669

1.23

3.32

1.8

1.7

5.34

4.04

mg/l

0.79

250

1940

Injuries to the wrist and hand

2378

14599

1.08

3.32

1.7

4.09

4.25

mg/l

0.21

1820

10646

Cervicocranial syndrome

219

1708

1.29

3.32

2.1

1.8

3.34

4.36

mg/l

0.60

169

1242

Lung diseases due to external agents

1291

0.68

3.31

2.2

1.8

10.91

5.21

mg/l

1.34

961

5-aminosalicylic acid

334

4062

0.82

3.30

1.6

1.5

4.31

3.99

mg/l

0.29

253

2897

Sensorineural hearing loss

1089

8108

0.89

3.30

1.7

1.8

4.69

4.53

mg/l

0.14

821

6149

Other septicaemia, including avohilmo

436

4861

0.84

3.29

2.1

1.7

8.05

4.33

mg/l

3.52

374

3570

Female genital prolapse

523

2463

1.19

3.29

1.6

1.7

3.26

4.64

mg/l

3.15

412

1863

Disorders of synovium and tendon

1219

9310

1.11

3.29

1.6

1.7

3.94

4.28

mg/l

0.63

985

6657

Hypertrophic cardiomyopathy

465

1.57

3.26

4.6

1.8

6.67

4.02

mg/l

1.25

353

Other disorders of urethra and urinary system

1521

9625

1.10

3.26

1.7

4.50

4.34

mg/l

0.21

1191

7060

Schizoaffective disorder

1387

0.69

3.25

1.9

1.8

4.62

4.25

mg/l

0.19

1014

Other external causes of accidental injury

1954

8992

1.09

3.23

1.7

4.60

4.18

mg/l

0.53

1496

6374

Medical treatment for female infertility

643

5537

1.16

3.22

1.6

1.7

4.15

3.93

mg/l

0.24

453

4029

Implicit bacterial Sepsis

452

4583

0.84

3.22

2.2

1.7

10.04

4.25

mg/l

6.89

402

3385

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

701

6129

1.15

3.20

1.6

1.7

4.27

4.20

mg/l

0.03

532

4423

Anorexia (incl.atypical)

156

1169

1.35

3.19

1.6

1.7

2.55

4.21

mg/l

1.71

112

805

Necrosis of pulp, including avohilmo

1176

12868

0.90

3.19

1.8

1.7

4.78

4.20

mg/l

0.57

948

9429

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

239

2997

0.79

3.18

1.7

1.8

4.18

4.25

mg/l

0.04

185

2170

Need for immunization against other single viral diseases

260

1.78

3.18

1.9

2.0

3.84

4.35

mg/l

0.14

195

Ptosis of eyelid

167

1263

1.33

3.18

1.8

1.7

3.09

4.31

mg/l

0.94

133

956

Hypothyroidism, drug reimbursement

367

2119

1.22

3.15

2.0

1.3

4.24

3.51

mg/l

0.97

310

1307

Mental and behavioural disorders due to psychoactive substance use

1030

10517

0.89

3.15

1.7

5.14

4.25

mg/l

1.84

904

7597

Hyperkinetic disorders (excl. ADHD)

309

1.70

3.15

1.3

1.8

5.07

3.11

mg/l

0.86

205

Non-invasive ventilation

402

4131

0.83

3.14

1.7

1.4

9.61

3.47

mg/l

7.59

318

2643

Somnolence

181

1.94

3.13

2.2

1.9

3.87

4.44

mg/l

0.15

133

Spermatocele

615

1.48

3.11

1.5

1.9

3.34

5.45

mg/l

0.85

455

Coronary revascularization (ANGIO or CABG)

1498

8284

1.10

3.11

3.3

1.5

7.26

3.79

mg/l

9.60

1268

6173

Metatarsalgia

210

1646

1.29

3.10

1.9

1.8

4.81

4.45

mg/l

0.16

167

1184

Oral corticosteroids

2452

13359

1.08

3.10

2.6

1.5

6.57

3.73

mg/l

14.21

2057

9609

Other and unspecified dermatitis

1092

9823

1.12

3.10

1.8

1.7

4.71

4.17

mg/l

0.84

873

7225

Otalgia

173

1322

1.32

3.09

2.1

1.8

4.43

4.47

mg/l

0.01

136

970

Persons encountering health services in other circumstances

893

7864

1.13

3.06

1.7

1.6

4.22

3.82

mg/l

0.79

721

5550

Anogenital herpesviral [herpes simplex] infection

179

1379

1.32

3.06

1.6

1.7

2.77

4.54

mg/l

2.55

138

979

Postprocedural disorders of nervous system

186

1440

1.31

3.06

1.8

4.59

4.38

mg/l

0.06

150

1040

Sphingolipidosis, other/unspecified

3.87

3.06

4.0

1.5

3.85

2.57

mg/l

0.19

Percutaneous Coronary Intervention

1494

8279

1.10

3.05

3.3

1.5

7.28

3.79

mg/l

9.65

1264

6168

Unstable angina pectoris

325

3095

0.82

3.05

2.0

1.5

6.94

3.90

mg/l

1.85

266

2282

Gonarthrosis [arthrosis of knee](FG)

1511

7925

1.10

3.04

1.8

1.7

4.80

3.97

mg/l

1.51

1266

5845

Other noninflammatory disorders of vagina

159

1204

1.34

3.04

1.9

1.8

3.71

4.72

mg/l

0.59

119

887

Crohn disease (strict definition, all UC cases excluded)

916

0.63

3.04

1.4

1.8

3.71

4.80

mg/l

0.64

667

Malignant neoplasm of ovary

606

0.55

3.02

1.5

1.7

9.41

4.26

mg/l

0.61

444

Neoplasms

2058

9975

1.09

3.01

1.6

4.03

4.08

mg/l

0.06

1517

7101

Malignant neoplasm of colon

113

1557

0.72

3.01

1.4

1.6

4.22

4.84

mg/l

0.31

1167

Artificial joint operation, meniscal resection

1736

10195

1.09

3.01

1.7

4.51

4.41

mg/l

0.10

1401

7620

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

569

4930

1.16

3.01

1.6

1.7

3.39

4.19

mg/l

1.25

439

3494

Polycystic ovarian syndrome, consortium definition

1832

9673

1.09

3.00

1.7

1.6

4.46

3.96

mg/l

0.78

1436

7048

Follow-up care involving plastic surgery

606

1.48

3.00

1.7

1.6

3.21

4.15

mg/l

0.41

451

Intracerebral haemorrhage

1074

0.67

2.99

1.7

4.98

5.26

mg/l

0.05

812

Inflammatory bowel disease

513

5956

0.86

2.99

1.6

1.7

4.73

4.22

mg/l

0.53

399

4366

Disorders of muscle in diseases classified elsewhere

6.09

2.99

14.3

1.8

3.06

3.66

mg/l

—

Alcohol-induced chronic pancreatitis

804

0.61

2.98

1.5

1.9

8.19

5.13

mg/l

0.47

598

Oedema, not elsewhere classified

580

4909

1.16

2.98

1.9

1.6

4.79

4.23

mg/l

0.63

487

3558

Crohn disease

181

2325

0.77

2.98

1.7

1.8

4.55

4.15

mg/l

0.25

141

1686

Alcohol abuse, main dg, excluding more controls

184

2359

0.77

2.97

1.6

1.8

5.41

4.39

mg/l

0.59

166

1616

Artrosis, including avohilmo

1824

9188

1.09

2.97

1.7

4.86

4.12

mg/l

1.11

1506

6708

Implicit viral Sepsis

329

2721

1.22

2.97

2.7

1.6

8.40

4.16

mg/l

3.73

284

1990

Angina pectoris

677

5125

0.87

2.96

2.0

1.5

6.48

3.74

mg/l

3.22

553

3798

Vulvovaginal ulceration/inflammation in other diseases

188

1465

1.30

2.96

1.7

3.62

4.18

mg/l

0.40

134

1041

Injury of muscle and tendon at lower leg level

286

2336

1.23

2.95

1.9

1.8

5.08

4.63

mg/l

0.17

214

1710

Autoimmune diseases related-to ILD

1652

14982

0.92

2.95

1.8

1.7

5.56

3.90

mg/l

5.07

1315

10921

Retention of urine

336

3270

0.83

2.95

1.6

1.7

5.25

4.87

mg/l

0.16

275

2435

Other disorders of patella

404

3412

1.19

2.94

1.6

1.8

4.85

3.91

mg/l

0.85

334

2432

Viral infections characterized by skin and mucous membrane lesions

854

7598

1.13

2.93

2.0

1.7

4.73

4.34

mg/l

0.34

676

5574

Viral Sepsis

329

2727

1.21

2.91

2.7

1.6

8.40

4.15

mg/l

3.74

284

1995

Other septicaemia

427

4733

0.85

2.90

2.2

1.7

8.08

4.34

mg/l

3.47

368

3478

Total colectomy operation

610

0.56

2.90

1.4

1.9

3.56

4.11

mg/l

0.30

451

Total colectomy

610

0.56

2.90

1.4

1.9

3.56

4.11

mg/l

0.30

451

Myocardial infarction, unclassifiable

113

1384

0.73

2.89

2.0

1.7

7.76

5.36

mg/l

0.59

1057

Alzheimer disease, including avohilmo

201

1768

0.78

2.89

1.5

1.7

6.52

4.79

mg/l

0.66

153

1370

Heart failure,strict

588

4716

0.87

2.89

3.8

1.6

7.21

4.17

mg/l

5.12

547

3460

Heart failure, strict

607

4838

0.87

2.88

3.7

1.6

7.35

4.50

mg/l

4.35

564

3601

Volume depletion

920

0.65

2.87

2.6

1.7

7.12

5.04

mg/l

0.39

673

Endometriosis of rectovaginal septum and vagina

141

1059

1.35

2.87

1.5

1.8

4.83

4.36

mg/l

0.20

104

773

Childhood asthma (age<16), excluding more controls

404

2665

1.19

2.87

1.5

1.4

4.61

3.31

mg/l

1.41

276

1669

Asymptomatic human immunodeficiency virus [HIV] infection status

2.38

2.86

1.3

1.6

2.42

5.07

mg/l

0.88

Presence of cardiac and vascular implants and grafts

578

3685

1.16

2.86

6.2

1.5

6.34

4.23

mg/l

2.37

517

2725

malignant neoplasm of male genital organs

282

2077

0.81

2.85

1.5

1.8

4.75

5.11

mg/l

0.14

212

1546

Cholelithiasis, broad definition with cholecystitis

1808

11102

1.09

2.84

1.9

1.7

5.54

4.11

mg/l

3.32

1539

8187

Other diseases of blood and blood-forming organs, wide

257

3155

0.81

2.84

1.9

1.7

6.99

4.33

mg/l

1.57

223

2348

Complications of procedures, not elsewhere classified

1769

13150

1.09

2.84

1.8

1.7

4.83

4.16

mg/l

1.53

1450

9653

Ulcerative rectosigmoiditis

103

1421

0.72

2.84

1.9

1.8

3.73

4.32

mg/l

0.33

1045

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

205

0.34

2.82

1.9

1.8

3.89

4.68

mg/l

—

161

Mild mental retardation

396

0.47

2.82

1.9

1.6

8.03

3.58

mg/l

1.33

277

Injury of muscle and tendon at shoulder and upper arm level

594

5185

1.15

2.81

1.7

1.8

4.46

4.64

mg/l

0.10

485

3884

Emergency coronary revascularization (for ACS)

1540

8520

1.09

2.81

3.2

1.5

7.46

3.82

mg/l

10.29

1300

6368

Dental operations

1080

6156

0.90

2.80

1.8

1.6

5.10

3.71

mg/l

1.48

823

4410

Arthropathies

2283

10734

1.08

2.80

1.7

1.6

4.59

4.00

mg/l

1.37

1798

7525

Other ulcerative colitis

982

0.66

2.79

1.6

1.8

4.92

4.58

mg/l

0.10

727

Childhood asthma (age<16)

404

2673

1.19

2.79

1.5

1.4

4.61

3.38

mg/l

1.30

276

1679

malignant neoplasm of male genital organs, including Hilmo

295

2152

0.82

2.78

1.5

1.8

4.80

5.16

mg/l

0.14

220

1602

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1032

0.67

2.78

1.3

1.7

4.74

5.20

mg/l

0.10

769

Premenstrual syndrome

287

1.69

2.78

1.5

2.0

3.98

3.75

mg/l

0.07

194

Memory loss

111

808

1.38

2.75

1.5

1.7

3.11

4.88

mg/l

1.25

621

Other diseases of stomach and duodenum

100

717

1.41

2.73

1.6

1.7

5.94

4.07

mg/l

0.49

526

Implicit Sepsis

1258

10150

0.91

2.72

2.2

1.7

7.32

3.96

mg/l

9.12

1066

7458

Renal failure

484

4771

0.86

2.69

2.3

1.7

9.21

4.47

mg/l

5.36

443

3555

Other enthesopathy of foot (+metatarsalgia)

222

1786

1.25

2.68

2.0

1.8

4.76

4.46

mg/l

0.13

178

1293

Ulcerative colitis

381

4482

0.85

2.68

1.6

1.7

4.77

4.32

mg/l

0.35

299

3273

Adenocarcinoma and papilloma adenocarcinoma of rectum

999

0.68

2.67

1.3

1.7

4.84

5.16

mg/l

0.07

746

Trochanteric bursitis

270

2218

1.23

2.67

1.8

1.7

4.72

4.50

mg/l

0.11

240

1619

Other neurological diseases

1061

9074

0.90

2.67

1.8

1.7

5.41

4.33

mg/l

1.44

839

6780

Other disorders starting during childhood or adolescence

132

985

1.34

2.66

1.5

1.6

4.55

3.78

mg/l

0.53

662

Malignant neoplasm of rectum

1021

0.68

2.65

1.3

1.7

4.74

5.09

mg/l

0.08

757

Artificial opening status

620

0.59

2.65

1.8

1.6

4.58

4.76

mg/l

0.04

460

Benign neoplasm: Testis

3.48

2.65

1.2

1.6

1.96

4.68

mg/l

—

Nausea and vomiting

486

4096

1.16

2.65

1.9

1.6

5.37

4.11

mg/l

1.27

413

2905

Hypopituitarism

144

1100

1.32

2.64

1.6

1.7

5.70

4.73

mg/l

0.25

111

802

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

100

723

1.40

2.63

1.8

4.38

4.51

mg/l

0.04

553

Impingement syndrome of shoulder

428

3669

1.17

2.63

1.8

1.7

4.77

4.56

mg/l

0.11

355

2683

Striking against or struck by other objects

739

6566

1.13

2.63

1.7

3.92

4.32

mg/l

0.46

577

4699

Ovarian dysfunction

237

1930

1.24

2.62

1.6

1.7

4.63

4.16

mg/l

0.39

192

1356

Otitis externa

459

3958

1.17

2.62

1.5

1.7

4.26

4.45

mg/l

0.14

367

2908

Acute alcohol intoxication ICD-9

371

0.48

2.59

1.3

1.9

11.36

4.24

mg/l

0.65

282

Overexertion and strenuous or repetitive movements

200

1598

1.26

2.59

1.9

1.7

5.29

4.56

mg/l

0.29

157

1175

Tic and related disorders

171

1.86

2.58

1.5

2.1

3.72

2.72

mg/l

0.54

105

Senile cataract

866

5866

0.89

2.58

1.9

1.8

4.84

4.44

mg/l

0.39

685

4432

Dementia in Alzheimer disease

793

0.67

2.58

1.4

1.6

11.81

4.55

mg/l

1.46

626

Unspecified visual impairment (binocular)

180

0.33

2.58

2.5

1.8

0.61

2.76

mg/l

—

135

Colectomy operation

146

1888

0.77

2.57

1.6

1.7

4.56

4.81

mg/l

0.12

120

1424

Colon adenocarcinoma

1167

0.71

2.56

1.4

1.7

4.20

5.06

mg/l

0.36

877

Myocardial infarction, without ST-elevation

332

3555

0.84

2.56

2.4

1.7

5.75

5.04

mg/l

0.37

272

2688

Kidney diseases associated to Fabry's disease

3.49

2.56

4.3

1.5

1.24

2.57

mg/l

—

Other hearing loss

349

2854

1.19

2.54

1.7

4.02

4.72

mg/l

0.52

271

2137

Other disorders of bone

408

3498

1.17

2.53

1.7

5.26

4.24

mg/l

0.71

314

2564

Gonarthrosis,primary

1604

8925

1.09

2.53

1.8

1.7

4.77

4.40

mg/l

0.51

1336

6752

Epilepsy

404

4692

0.85

2.52

1.7

6.38

4.15

mg/l

1.87

321

3270

Type 2 diabetes, definitions combined, including avohilmo

1915

11891

0.93

2.52

2.3

1.6

5.57

4.01

mg/l

6.79

1729

8486

Suicide or other Intentional self-harm

553

4850

1.15

2.51

1.6

1.7

4.86

4.25

mg/l

0.85

481

3533

Exclusions for E4_PCOS_BROAD

343

2899

1.19

2.50

1.8

1.7

4.74

4.28

mg/l

0.27

273

2123

Injury of muscle and tendon at hip and thigh level

203

1632

1.25

2.50

1.5

1.8

4.77

4.66

mg/l

0.04

150

1205

Other maternal disorders predominantly related to pregnancy

1486

8568

1.09

2.49

1.7

4.27

3.98

mg/l

0.50

1177

6204

Other and unspecified diseases of spleen

0.00

2.49

0.0

1.8

—

5.92

—

Hypertension, essential

1801

9443

1.08

2.49

1.9

1.7

5.36

3.82

mg/l

3.60

1572

6790

Poisoning by medicine

512

4472

1.15

2.48

1.7

4.66

4.23

mg/l

0.50

449

3244

Other benign neoplasms of skin

630

5574

1.13

2.48

1.6

1.7

4.06

4.42

mg/l

0.31

464

4175

Hypertrophic scar

122

922

1.34

2.46

1.5

1.7

4.34

4.69

mg/l

0.11

100

667

Substance abuse

1004

10257

0.91

2.46

1.7

5.17

4.28

mg/l

1.80

885

7417

Dermatitis

1300

11679

1.09

2.46

1.7

4.67

4.17

mg/l

0.82

1032

8585

Maternal care for other known or suspected fetal problems

772

4329

1.13

2.46

1.6

1.7

4.36

4.18

mg/l

0.18

573

3114

Primary gonarthrosis, bilateral

789

5915

1.12

2.46

1.7

1.8

5.58

4.62

mg/l

1.02

686

4431

Thyrotoxicosis, other and/or unspecified

397

3408

1.17

2.43

2.6

1.7

4.32

4.46

mg/l

0.09

322

2497

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

399

3430

1.17

2.42

1.6

1.7

4.85

4.31

mg/l

0.56

348

2479

Supernumerary teeth EXCLUDE clefts and syndromes

2.63

2.42

1.1

1.5

5.60

4.27

mg/l

—

Polycystic ovarian syndrome, broad definition

347

2954

1.19

2.41

1.8

1.6

4.56

4.08

mg/l

0.36

274

2054

Transient ischemic attack

582

5249

0.88

2.39

1.8

1.7

5.63

4.59

mg/l

0.80

451

3969

Umbilical hernia

498

4353

1.15

2.38

1.8

1.7

5.44

4.19

mg/l

0.58

407

3246

External causes of morbidity and mortality

1613

7477

1.08

2.38

1.8

1.6

4.62

4.02

mg/l

0.74

1225

5197

Crohn's disease of small intestine

1250

0.73

2.37

1.9

1.8

5.02

4.69

mg/l

0.12

902

Deficiency of other B group vitamins

237

1.68

2.36

1.7

1.8

3.86

3.78

mg/l

0.02

175

Aplastic and other anaemias

512

5337

0.87

2.35

1.8

1.7

6.85

4.63

mg/l

2.57

438

3987

conjunctival haemorrhage

113

850

1.34

2.34

1.9

1.8

2.88

4.77

mg/l

1.32

639

Myopia

321

2723

1.19

2.32

1.6

1.7

4.26

4.24

mg/l

0.01

238

1956

Other viral diseases, including avohilmo

938

8439

1.10

2.32

1.7

4.87

4.11

mg/l

0.91

713

6083

Ulcerative colitis (strict definition, all Crohn cases excluded)

212

2587

0.81

2.31

1.7

4.05

4.18

mg/l

0.07

164

1868

Sexual dysfunction

294

1.60

2.30

2.0

1.7

3.28

4.80

mg/l

0.74

211

Suppurative and necrotic conditions of lower respiratory tract

607

0.62

2.28

1.6

1.9

4.42

4.96

mg/l

0.14

453

Physiological and behavioural disorders associated with sexual development and orientation

3.66

2.26

1.9

2.02

2.60

mg/l

—

Cystic kidney disease, including avohilmo

480

0.57

2.26

1.8

2.45

3.90

mg/l

1.28

347

Hydronephrosis

108

1424

0.75

2.25

1.7

7.56

4.33

mg/l

1.11

1039

Other symptoms and signs involving cognitive functions and awareness

736

5855

1.12

2.25

1.8

1.7

4.13

4.64

mg/l

0.54

595

4341

Persistent delusional disorders

1009

0.71

2.25

1.7

1.8

3.93

4.74

mg/l

0.36

753

Other viral hepatitis, including avohilmo

1249

0.74

2.24

1.4

1.8

4.35

4.29

mg/l

0.03

891

Use of glatiramer acetate

348

0.50

2.23

1.4

1.7

2.29

3.05

mg/l

—

245

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

715

6347

1.12

2.23

1.6

4.31

4.05

mg/l

0.30

573

4544

Malignant neoplasm of prostate, including Hilmo

278

1956

0.84

2.23

1.4

1.8

4.42

5.14

mg/l

0.34

208

1461

Granuloma annulare

242

1.65

2.22

1.5

1.7

5.55

2.91

mg/l

0.57

176

ILD medications

2645

13450

1.06

2.21

2.6

1.4

5.91

3.68

mg/l

11.26

2207

9530

Golimumab

660

0.64

2.21

1.3

1.8

5.48

4.64

mg/l

0.16

486

Non-Hodgkin lymphoma, all, including Hilmo

109

1431

0.76

2.21

1.4

1.7

7.21

4.87

mg/l

0.59

1065

Chronic conjunctivitis

427

1.48

2.20

1.4

1.9

4.07

5.12

mg/l

0.23

312

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1162

9288

1.09

2.20

2.1

1.7

5.91

4.27

mg/l

2.76

957

6949

Retinal detachment with retinal break

179

1442

1.25

2.19

1.8

1.7

4.05

4.70

mg/l

0.30

139

1081

Hernia of abdominal wall

800

7234

1.11

2.19

1.7

5.78

4.33

mg/l

1.20

657

5395

Car occupant injured in other and unspecified transport accidents

417

3628

1.16

2.19

1.6

1.7

4.20

4.39

mg/l

0.18

336

2627

Sudden idiopathic hearing loss

157

1247

1.27

2.18

1.6

1.8

4.20

4.45

mg/l

0.10

118

922

Macular pucker

185

1496

1.24

2.18

1.7

3.91

4.41

mg/l

0.18

139

1141

Atrophic disorders of skin

299

2535

1.19

2.18

2.1

1.7

4.56

4.49

mg/l

0.03

240

1890

Malignant neoplasm of prostate

269

1899

0.84

2.18

1.5

1.8

4.31

5.16

mg/l

0.45

203

1410

Superficial injury of abdomen, lower back and pelvis

315

2683

1.18

2.17

1.6

1.7

4.98

4.34

mg/l

0.45

247

1955

Diseases of appendix

1691

14102

1.07

2.17

1.8

1.7

3.93

4.25

mg/l

0.67

1290

10375

Conductive and sensorineural hearing loss

1237

8902

0.92

2.16

1.7

1.8

4.68

4.49

mg/l

0.17

925

6737

Use of interferon beta-1a

459

0.58

2.16

1.5

1.7

4.54

3.65

mg/l

0.21

330

Malignant neoplasm of larynx, including Hilmo

167

0.35

2.16

1.2

1.6

9.90

4.87

mg/l

—

120

Type 2 diabetes, strict (exclude DM1)

1906

11836

0.93

2.15

2.3

1.6

5.62

4.01

mg/l

6.76

1714

8483

Hypo-osmolality and hyponatraemia

149

1860

0.79

2.15

2.2

1.7

5.60

4.59

mg/l

0.48

128

1366

Iron deficiency anaemia

713

6289

1.12

2.15

1.9

1.7

4.88

4.30

mg/l

0.59

582

4681

Outcome of delivery

490

2640

1.15

2.15

1.6

1.7

2.95

4.33

mg/l

3.26

331

1988

Appendicitis, broad definition

1681

14074

1.07

2.14

1.8

1.7

3.90

4.26

mg/l

0.79

1281

10357

Other diseases of lip and oral mucosa

837

7597

1.11

2.14

1.7

4.01

4.31

mg/l

0.41

653

5640

Excessive attrition of teeth

1455

13378

1.08

2.14

1.8

1.7

4.46

4.16

mg/l

0.26

1093

9815

Conjunctivitis (acute, non atopic)

605

5375

1.13

2.13

1.6

1.7

4.19

4.33

mg/l

0.14

474

3916

Chronic viral hepatitis

984

0.71

2.12

1.5

1.8

4.16

3.96

mg/l

0.08

699

Generalized epilepsy

749

0.67

2.11

1.4

1.8

4.61

3.91

mg/l

0.26

536

Lichen ruber planus, wide definition including periferal and oral lichen planus

379

3283

1.16

2.11

1.9

1.7

5.34

4.50

mg/l

0.60

301

2478

Other and unspecified tonsillitis

915

6932

1.10

2.11

1.8

1.6

4.80

3.93

mg/l

1.23

701

4771

Poisoning by drugs, medicaments and biological substances

551

4897

1.13

2.10

1.7

4.65

4.19

mg/l

0.58

483

3537

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

991

8959

1.10

2.10

1.8

1.7

4.51

4.09

mg/l

0.60

792

6374

Heart failure, not strict

1121

8187

0.92

2.10

3.3

1.6

7.43

4.08

mg/l

6.91

1024

6064

Other and unspecified effects of external causes

620

5548

1.12

2.10

1.6

1.7

4.55

4.23

mg/l

0.33

480

4026

Dysphagia

396

3444

1.15

2.08

1.8

1.7

5.84

4.15

mg/l

1.00

299

2505

Poor fetal growth

274

3224

0.84

2.07

1.4

1.6

4.84

4.13

mg/l

0.54

186

2298

Chronic lower respiratory diseases

2813

14032

1.06

2.07

1.8

1.6

5.72

3.85

mg/l

7.63

2222

10125

Pyothorax

468

0.59

2.06

1.8

3.66

5.41

mg/l

0.50

356

Disorders of sclera, cornea, iris and ciliary body

1129

10408

1.09

2.06

1.8

1.7

4.50

4.27

mg/l

0.26

863

7678

Arthrosis

1504

7656

1.08

2.06

1.7

4.72

4.13

mg/l

0.90

1260

5576

Viral warts, including avohilmo

483

4265

1.14

2.05

1.8

1.7

4.55

4.23

mg/l

0.18

370

3076

Hypoglycaemia, other or unspecified

122

948

1.30

2.05

2.0

1.7

3.06

4.65

mg/l

1.18

106

693

Type 2 diabetes, definitions combined

1905

11806

0.94

2.05

2.3

1.6

5.63

4.00

mg/l

6.90

1714

8455

Complications associated with artificial fertilization

336

1.52

2.04

1.3

1.9

2.48

3.48

mg/l

1.13

228

Type 2 diabetes

2039

12543

0.94

2.04

2.2

1.6

5.43

3.97

mg/l

6.71

1856

8925

Emotional disorders and disorders of social functioning with onset specific to childhood

131

1008

1.29

2.03

1.5

1.6

5.15

3.60

mg/l

1.36

105

678

Malignant neoplasm of urinary organs, including Hilmo

1140

0.74

2.03

1.6

1.7

6.22

5.13

mg/l

0.31

847

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

250

2091

1.20

2.03

1.6

1.7

3.64

4.43

mg/l

0.96

182

1495

Other arthrosis

1016

6239

1.09

2.01

1.7

4.06

4.19

mg/l

0.14

792

4602

Thyroiditis, unspecified

233

1.63

2.01

1.7

1.9

2.99

3.17

mg/l

0.08

172

Follicular lymphoma, hilmo

439

0.59

2.00

1.4

1.8

4.30

5.32

mg/l

0.15

342

Deep endometriosis

195

1608

1.22

1.98

1.6

1.7

4.49

4.14

mg/l

0.17

146

1172

Multiple myeloma, including Hilmo

400

0.57

1.98

1.6

1.7

7.64

4.19

mg/l

0.45

299

Multiple myeloma and malignant plasma cell neoplasms

400

0.57

1.97

1.6

1.7

7.64

4.16

mg/l

0.46

322

Dementia in other diseases classified elsewhere

387

0.56

1.97

1.7

1.8

3.14

4.17

mg/l

0.42

301

Hair colour and hair shaft abnormalities

2.84

1.97

1.2

1.7

2.10

6.33

mg/l

—

Juvenile arthritis (FINNGEN)

889

0.71

1.97

1.6

1.7

4.40

4.53

mg/l

0.04

603

Alzheimer disease

171

1503

0.81

1.96

1.5

1.6

7.05

4.99

mg/l

0.71

133

1177

Lateral epicondylitis

201

2419

0.83

1.96

1.6

1.8

4.32

4.48

mg/l

0.09

165

1754

Redundant prepuce, phimosis and paraphimosis

335

2848

1.16

1.95

1.8

3.18

4.51

mg/l

2.25

251

2026

Benign leiomyoma with endometriosis

253

2139

1.19

1.95

1.5

1.8

4.22

4.24

mg/l

0.01

185

1633

Abnormal findings on diagnostic imaging of lung

691

5912

1.11

1.95

2.3

1.7

6.88

4.42

mg/l

2.98

584

4426

Chondropathies

303

2603

1.17

1.93

1.7

5.21

4.27

mg/l

0.48

230

1909

Acute appendicitis

1586

13771

1.07

1.93

1.8

1.7

3.85

4.28

mg/l

1.02

1211

10139

Dyshidrosis [pompholyx]

284

1.55

1.92

1.7

1.9

3.08

3.70

mg/l

0.39

204

Macular cyst

291

1.53

1.92

1.8

3.61

5.86

mg/l

0.46

237

Malignant neoplasm of other and unspecified parts of biliary tract

155

0.38

1.92

2.0

1.9

2.84

4.77

mg/l

—

117

Hypermobility syndrome

142

1138

1.26

1.91

1.9

1.7

3.97

4.26

mg/l

0.16

113

805

Inguinal or femoral hernia, bilateral

129

1019

1.27

1.91

1.9

1.7

5.88

4.18

mg/l

0.43

766

Duodenal ulcer

933

0.73

1.90

1.5

1.8

7.23

4.39

mg/l

0.66

691

Other specified and unspecified disorders of eye and adnexa

491

1.40

1.90

2.2

1.8

2.46

4.71

mg/l

1.11

364

Non-follicular lymphoma

932

0.72

1.90

1.4

1.7

6.07

4.69

mg/l

0.22

698

Secondary and unspecified malignant neoplasm of lymph nodes

1000

0.73

1.89

1.3

1.8

6.08

4.89

mg/l

0.20

729

Malignant neoplasm of other and ill-defined sites, including Hilmo

143

0.34

1.89

1.4

2.1

35.96

4.42

mg/l

—

111

Dermatophytosis, including avohilmo

1409

12881

1.07

1.88

1.6

1.7

3.88

4.31

mg/l

0.88

1042

9458

Other and unspecified mononeuropathies, also in other diseases

350

1.48

1.88

1.6

1.8

2.93

5.45

mg/l

0.84

269

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1321

9046

1.08

1.87

1.8

1.6

3.59

4.12

mg/l

1.25

943

6720

GI-bleeding

328

3778

0.87

1.86

1.5

1.7

6.86

4.61

mg/l

0.79

270

2808

Nutritional anaemias

813

7076

1.10

1.86

1.9

1.7

4.94

4.30

mg/l

0.72

669

5268

Other obstructive and reflux uropathy

658

0.68

1.86

1.5

1.6

3.55

3.73

mg/l

0.07

480

Cardiodefibrillation

405

3550

1.14

1.85

3.3

1.7

5.90

5.00

mg/l

0.59

344

2685

Diabetes, varying definitions

2171

13304

0.94

1.85

2.2

1.6

5.32

3.93

mg/l

6.76

1975

9411

Habitual aborter

419

1.44

1.85

2.1

2.0

2.43

3.85

mg/l

1.59

286

Malignant neoplasm of cervix uteri

326

0.54

1.85

1.7

2.08

2.74

mg/l

0.77

224

Dyspnoea

1892

12855

1.06

1.84

2.0

1.7

5.76

4.12

mg/l

5.46

1574

9448

Subarachnoid haemorrhage

1121

0.75

1.84

1.6

1.7

4.92

4.49

mg/l

0.08

844

Atopic dermatitis, strict definition with reimbursement

790

6930

1.10

1.84

1.6

4.14

3.94

mg/l

0.25

600

4900

Any operation in hilmo

102

397

1.32

1.84

1.6

1.3

4.12

3.27

mg/l

0.38

233

Benign neoplasm of middle ear and respiratory system

119

937

1.28

1.84

2.1

1.8

4.64

4.95

mg/l

0.08

695

Barrett oesophagus

545

1.37

1.84

1.6

1.9

6.57

3.86

mg/l

0.56

407

Vitamin deficiency

632

1.34

1.82

1.6

3.99

3.97

mg/l

0.01

446

Vitamin deficiency, wide

632

1.34

1.82

1.6

3.99

3.97

mg/l

0.01

446

Other superficial mycoses, including avohilmo

248

2109

1.18

1.82

1.5

1.7

3.82

4.40

mg/l

0.34

179

1513

Small fibre neuropathy

353

1.47

1.81

1.5

1.8

6.43

3.70

mg/l

0.49

269

Other disorders of conjunctiva

204

1705

1.20

1.81

2.0

1.7

3.89

4.79

mg/l

0.54

156

1284

Other disorders of glucose regulation and pancreatic internal secretion

144

1163

1.25

1.80

1.9

1.7

3.24

4.75

mg/l

1.29

124

851

Certolizumab pegol

398

0.59

1.80

1.3

1.8

4.25

3.12

mg/l

0.32

285

Other viral hepatitis

1170

0.76

1.79

1.5

1.8

4.05

4.34

mg/l

0.12

838

Specific development disorders of scholastic skills

108

827

1.29

1.79

1.6

1.7

5.12

3.77

mg/l

0.87

560

Colon adenocarcinoma, helper endpoint

1094

0.76

1.79

1.4

1.7

4.20

5.04

mg/l

0.35

842

Hypertrophic disorders of skin

128

1022

1.27

1.79

1.5

1.7

4.36

4.62

mg/l

0.09

105

736

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1557

13303

1.07

1.79

1.6

1.7

4.23

4.11

mg/l

0.17

1144

9690

Insulin, fast-acting

536

5964

0.90

1.79

1.8

1.7

5.31

4.22

mg/l

1.29

498

4339

Vasomotor rhinitis (mode)

132

1058

1.26

1.78

1.6

1.7

5.49

4.30

mg/l

0.44

102

791

Need for other prophylactic measures

103

801

1.30

1.78

2.5

1.8

3.21

4.84

mg/l

1.06

588

Other viral diseases, not elsewhere classified, including avohilmo

615

5527

1.11

1.77

1.7

4.41

4.14

mg/l

0.21

464

4004

Speech and linguistic disorders

198

1586

1.21

1.77

1.6

5.29

4.08

mg/l

0.73

157

1091

Olecranon bursitis

740

1.31

1.76

2.2

1.9

2.34

5.94

mg/l

3.15

538

Crushed, pushed or stepped on by crowd or human stampede

175

1448

1.22

1.76

1.5

1.7

3.41

4.54

mg/l

1.02

122

1015

Other shoulder lesions

191

1593

1.21

1.76

1.9

1.7

5.78

4.49

mg/l

0.44

158

1142

Other disorders of male genital organs

456

1.40

1.75

1.9

1.7

4.93

4.52

mg/l

0.07

334

Problems related to lifestyle

160

1943

0.82

1.75

1.7

6.16

3.85

mg/l

2.30

143

1369

Malignant neoplasm of bladder, including Hilmo

907

0.74

1.75

1.6

1.7

8.92

5.61

mg/l

0.70

670

Anisometropia and aniseikonia

423

1.41

1.74

1.4

1.7

2.51

5.10

mg/l

1.14

314

Ehlers-Danlos syndrome, including avohilmo

292

1.52

1.74

2.0

1.7

3.30

3.10

mg/l

0.08

205

Melanocytic naevi of upper limb, including shoulder

383

0.59

1.74

1.5

1.8

4.94

3.87

mg/l

0.22

281

Thyrotoxicosis

473

4222

1.13

1.74

2.4

1.7

4.66

4.29

mg/l

0.31

384

3144

Sub-endpoint used in defining T1D endpoints

423

4687

0.88

1.74

1.6

1.7

4.39

4.29

mg/l

0.08

396

3390

Major coronary heart disease event

1533

8590

1.07

1.74

3.2

1.5

7.18

3.78

mg/l

9.78

1292

6411

Other diseases of pancreas

962

0.74

1.73

1.5

1.8

6.89

3.90

mg/l

0.63

704

Condition for Implicit Sepsis (Organ dysfunction codes)

1593

11735

0.94

1.73

2.2

1.6

6.53

3.92

mg/l

7.46

1310

8612

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

483

1.38

1.73

1.8

5.11

4.87

mg/l

0.04

361

Congenital malformations and deformations of the musculoskeletal system

199

1660

1.20

1.73

1.6

1.7

3.69

4.41

mg/l

0.67

151

1170

Inguinal hernia, bilateral

125

998

1.26

1.73

1.9

1.7

5.29

4.22

mg/l

0.24

749

Hallux rigidus

211

1778

1.19

1.72

1.4

1.8

4.24

4.30

mg/l

0.02

169

1278

Malignant neoplasm of stomach, including Hilmo

542

0.66

1.72

1.4

1.8

10.52

5.26

mg/l

0.85

403

Implicit Sepsis, including avohilmo

1496

11381

0.94

1.71

2.2

1.6

6.75

3.96

mg/l

8.15

1239

8376

Acute and transient psychotic disorders

168

2023

0.82

1.70

1.6

1.7

4.44

4.33

mg/l

0.06

141

1485

Falls/tendency to fall

2598

12382

1.05

1.69

1.7

4.64

4.10

mg/l

1.02

2015

8852

Diabetes mellitus

2190

13323

0.95

1.69

2.2

1.6

5.28

3.93

mg/l

6.54

1994

9415

Insulin, fast-acting or short human

539

5972

0.90

1.68

1.8

1.7

5.29

4.29

mg/l

1.16

501

4366

Restrictive cardiomyopathy

3.26

1.68

10.5

1.7

20.55

3.46

mg/l

—

Malignant neoplasm of corpus uteri, including Hilmo

1002

0.75

1.68

1.5

1.7

5.68

4.22

mg/l

0.56

765

Inflammatory disease of uterus

343

3012

1.15

1.67

1.7

3.35

4.17

mg/l

1.59

283

2182

Right hemicolectomy

526

0.66

1.67

2.0

1.7

6.07

5.32

mg/l

0.14

411

Bitten or struck by other mammals

262

2257

1.17

1.67

2.0

1.8

3.58

4.41

mg/l

1.09

202

1637

Gout

257

2563

0.86

1.66

2.3

1.7

7.00

4.81

mg/l

1.45

228

1859

Other diseases of intestine

237

2024

1.18

1.66

1.8

1.7

6.05

4.47

mg/l

0.75

188

1514

Generalized epilepsy, mode (most common among epilepsy diagnosis)

547

0.67

1.66

1.4

1.8

5.19

3.91

mg/l

0.40

394

UC patients in KELA-register (code 208), prior to 1994

548

0.67

1.66

1.4

1.8

4.46

5.02

mg/l

0.11

414

Other and unspecified psoriasis

908

0.74

1.65

1.8

1.7

3.41

4.90

mg/l

0.94

679

Traumatic amputation of wrist and hand

512

0.66

1.65

1.7

1.73

4.64

mg/l

3.99

390

Thyroiditis

142

1159

1.24

1.65

2.0

1.7

4.26

4.38

mg/l

0.04

108

850

Benign neoplasm: Stomach

134

1086

1.24

1.65

1.9

1.7

8.28

4.37

mg/l

1.28

108

827

Malignant neoplasm of mesothelium and soft tissue

415

0.62

1.64

1.8

10.68

5.19

mg/l

0.43

300

Granulomatous disorders of skin and subcutaneous tissue

429

1.40

1.64

1.4

1.7

4.04

4.77

mg/l

0.15

307

Pneumonia derived septicemia

438

0.63

1.63

1.2

1.8

4.37

3.65

mg/l

0.22

325

Malignant neoplasm of larynx

133

0.37

1.63

1.2

1.7

11.70

4.81

mg/l

—

100

Other systemic involvement of connective tissue (FG)

443

3883

1.12

1.62

1.7

6.14

3.94

mg/l

2.30

363

2763

Malignant neoplasm of corpus uteri

883

0.74

1.62

1.5

1.7

5.07

4.28

mg/l

0.28

676

Calculus of kidney and ureter

454

4061

1.12

1.62

1.7

4.86

4.72

mg/l

0.08

354

3003

Stomatitis and related lesions

386

3422

1.13

1.62

1.9

1.7

4.50

4.28

mg/l

0.14

290

2512

Parasetamol

1867

8915

1.06

1.62

1.8

1.6

5.23

3.44

mg/l

4.58

1516

5898

Superficial injury of wrist and hand

471

4226

1.12

1.61

1.8

1.7

3.97

4.25

mg/l

0.33

370

2996

Oral lichen planus and hypothyroidism or thyroxine medication

255

1.52

1.61

2.0

1.9

3.47

5.15

mg/l

0.33

201

Sequelae of injuries of lower limb

179

1499

1.20

1.61

1.7

1.8

3.64

4.61

mg/l

0.58

152

1109

Other diseases of biliary tract

927

0.75

1.61

1.6

1.7

9.35

3.87

mg/l

0.94

685

Malignant neoplasm of eye and adnexa, including Hilmo

172

0.46

1.60

4.5

1.8

4.06

3.62

mg/l

—

128

Psoriasis (vulgaris), strict definition

543

0.67

1.60

1.6

1.9

5.80

5.22

mg/l

0.13

393

Secondary malignant neoplasm of respiratory and digestive organs

171

0.46

1.60

1.5

1.7

8.54

5.26

mg/l

—

129

Inflammatory bowel disease treatment related agents

2631

13915

1.05

1.60

2.6

1.5

6.05

3.73

mg/l

12.24

2176

9954

Malignant neoplasm of cervix uteri, including Hilmo

410

0.62

1.59

1.6

1.7

2.06

4.89

mg/l

1.17

286

Diverticular disease of intestine

1265

7358

1.07

1.59

1.8

4.91

4.50

mg/l

0.51

1032

5544

Labour and delivery complicated by fetal stress [distress]

753

4493

1.10

1.58

1.6

3.74

4.14

mg/l

0.62

537

3212

Multiple delivery

143

1732

0.82

1.58

1.7

1.8

4.81

4.26

mg/l

0.14

104

1308

Persons with potential health hazards related to communicable diseases

828

8882

0.92

1.58

1.6

3.94

4.10

mg/l

0.16

600

6364

Cervicobrachial syndrome

448

4014

1.12

1.58

1.7

1.8

3.77

4.15

mg/l

0.37

353

2948

Abdominal aortic aneurysm (AAA)

527

0.67

1.57

1.7

10.59

5.34

mg/l

0.82

403

Lactose intolerance

475

1.36

1.57

1.7

3.04

5.20

mg/l

0.86

333

Diabetic retinopathy, strict definition

236

1797

1.17

1.57

1.6

2.3

4.34

5.58

mg/l

1.55

221

1617

Gingivitis and periodontal diseases

2017

10977

0.95

1.57

1.9

1.6

5.30

3.89

mg/l

3.06

1547

7917

Dermatitis due to substances taken internally

100

790

1.28

1.56

2.5

1.8

4.28

3.91

mg/l

0.21

577

Other peripheral vertigo

139

1139

1.23

1.56

1.7

3.07

4.64

mg/l

1.36

118

860

Vitreous haemorrhage

147

1212

1.22

1.55

1.7

4.43

4.83

mg/l

0.17

124

892

First line medication for Crohn's disease

2579

13233

1.05

1.55

2.5

1.4

5.67

3.73

mg/l

9.04

2122

9379

Additional codes for the location of defect, injury or illness

852

0.74

1.55

1.6

1.8

3.83

4.51

mg/l

0.23

619

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

738

0.73

1.55

1.6

1.7

6.56

5.12

mg/l

0.19

537

Amyloidosis, other/unspecified

161

1.64

1.54

1.5

1.7

5.80

4.12

mg/l

0.33

125

Arthropathy in Crohn disease

185

0.47

1.54

1.3

1.8

3.10

3.16

mg/l

—

136

Infliximab

406

0.63

1.54

1.2

1.9

8.75

3.70

mg/l

0.35

280

Enteropathic arthropathies

382

0.62

1.54

2.9

1.8

2.70

5.60

mg/l

1.00

269

Other systemic involvement of connective tissue

452

4058

1.12

1.54

1.8

1.7

6.06

4.28

mg/l

1.68

371

3008

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1010

0.77

1.53

1.6

1.7

6.33

5.33

mg/l

0.25

748

Complications of labour and delivery

1491

7793

1.07

1.53

1.7

3.66

4.12

mg/l

1.36

1092

5747

Preterm labour and delivery

481

5325

0.90

1.52

1.8

1.7

4.67

4.20

mg/l

0.47

388

3976

Hirsutism in women

445

1.38

1.52

1.5

1.7

3.95

3.58

mg/l

0.23

306

Tramadol

1741

9897

1.06

1.51

1.8

1.7

5.58

3.72

mg/l

4.79

1508

7025

Dialysis, with operation codes

183

1545

1.19

1.51

2.3

1.8

11.93

4.09

mg/l

4.61

171

1142

Bacterial, viral and other infectious agents

167

1400

1.20

1.51

2.2

1.8

6.20

4.53

mg/l

0.61

129

1029

Cerebral cysts

115

929

1.25

1.50

1.6

1.7

4.87

4.25

mg/l

0.27

673

Supervision of normal pregnancy

619

3218

1.10

1.50

1.5

1.7

4.06

4.22

mg/l

0.13

433

2444

Other and unspecified rosacea

173

1457

1.20

1.48

1.8

1.7

4.28

4.33

mg/l

0.03

147

1073

Injury of muscle and tendon at wrist and hand level

185

2178

0.84

1.48

1.6

1.8

4.78

4.55

mg/l

0.11

141

1588

Fibrosis and cirrhosis of liver

903

0.76

1.48

2.2

1.7

5.72

4.77

mg/l

0.43

677

Generalized epilepsy, strict definition

402

0.64

1.48

1.5

1.9

3.24

3.59

mg/l

0.20

278

Concussion

1163

8436

1.07

1.48

1.9

1.6

4.17

3.80

mg/l

0.54

929

5728

Acute bronchitis

718

6477

1.09

1.48

1.8

1.7

6.55

4.15

mg/l

3.75

592

4767

Carcinoma in situ of skin

742

1.27

1.48

2.6

1.8

6.49

4.85

mg/l

0.35

579

Other and unspecified nerve root and plexus disorders, also in other diseases

400

3578

1.12

1.47

1.7

5.91

4.43

mg/l

0.98

313

2609

Conductive hearing loss, unspecified

144

1193

1.22

1.47

1.4

1.7

3.75

4.61

mg/l

0.60

102

869

Cluster headache, strict

647

1.30

1.47

1.9

1.8

3.00

4.16

mg/l

0.62

431

Personal history of certain other diseases

424

0.65

1.46

1.6

1.5

4.81

3.51

mg/l

0.40

289

472

0.67

1.46

1.4

1.7

5.08

3.17

mg/l

0.80

318

Lumbosacral root disorders, not elsewhere classified

154

0.45

1.45

1.4

1.9

2.42

2.83

mg/l

—

122

Asthma, unspecified (mode), excluding more controls

1171

7844

1.07

1.45

2.0

1.4

6.26

3.49

mg/l

5.28

990

5509

Vocal cord dysfunction

295

2279

1.14

1.45

2.0

1.4

3.93

3.92

mg/l

0.01

227

1468

Ulcer of oesophagus

649

0.72

1.45

1.5

1.8

5.54

4.23

mg/l

0.27

488

Other and unspecified anaemias

472

4900

0.90

1.45

1.8

1.7

6.53

4.64

mg/l

2.07

405

3666

Prominent ears

189

1.58

1.44

1.3

1.6

2.84

3.63

mg/l

0.37

117

Lichen planus, including avohilmo

308

2716

1.14

1.44

1.8

1.7

5.73

4.40

mg/l

0.91

246

2052

Atopic conjunctivitis

791

1.26

1.44

1.3

1.9

3.73

4.92

mg/l

0.68

576

Parkinson's disease, excluding more controls

102

1167

0.80

1.44

1.4

1.6

2.92

4.65

mg/l

1.87

831

Superficial injury of thorax

262

2286

1.15

1.44

1.7

4.55

4.46

mg/l

0.04

215

1673

Optic neuritis

760

0.74

1.43

1.7

3.29

3.74

mg/l

0.24

554

Other diseases of the digestive system

339

3815

0.89

1.43

1.5

1.7

6.78

4.58

mg/l

0.81

280

2841

Nephropathy related operations

176

1490

1.19

1.43

2.3

1.8

11.35

4.27

mg/l

4.01

162

1108

Disorders of mineral metabolism

130

1070

1.22

1.42

1.9

1.8

4.38

4.57

mg/l

0.06

113

771

Disorders of iron metabolism

238

1.50

1.42

1.6

1.8

1.81

3.26

mg/l

1.47

176

Deforming dorsopathies

536

4877

1.10

1.42

1.8

1.7

4.83

4.10

mg/l

0.69

419

3541

Malignant neoplasm of head and neck

874

0.76

1.42

1.3

1.8

4.15

5.39

mg/l

0.45

644

Alzheimer’s disease (Early onset)

314

0.60

1.41

1.3

2.0

13.79

5.10

mg/l

0.69

250

Glaucoma

692

6378

0.92

1.41

1.7

4.65

4.53

mg/l

0.08

549

4826

Budesonide

218

2521

0.86

1.41

1.6

1.5

3.66

4.01

mg/l

0.35

169

1801

Infarction of spleen

2.13

1.41

1.5

1.7

7.36

3.53

mg/l

0.61

Benign neoplasm of eye and adnexa

162

1364

1.19

1.40

2.1

1.7

4.95

4.53

mg/l

0.12

126

1026

Gout, FINNGEN

257

2920

0.87

1.40

2.3

1.7

7.00

4.89

mg/l

1.39

228

2188

Guttate psoriasis

236

0.54

1.40

5.2

1.9

2.40

3.62

mg/l

—

176

Drug-induced acute pancreatitis

2.76

1.40

2.3

1.4

21.60

2.52

mg/l

—

L02BB Anti-androgens

529

0.70

1.40

1.6

6.47

4.84

mg/l

0.36

395

Other anaemias

478

4933

0.90

1.40

1.8

1.7

6.54

4.63

mg/l

2.12

410

3696

Cervical polyps

166

1402

1.19

1.39

1.7

1.8

3.66

4.78

mg/l

0.74

130

1066

Other abnormal products of conception

974

5959

1.08

1.39

1.7

3.91

4.15

mg/l

0.31

692

4354

Other follicular disorders

164

1385

1.19

1.39

1.5

1.8

6.61

4.41

mg/l

2.13

149

997

Short Achilles tendon (acquired)

420

0.66

1.39

1.9

1.7

6.69

5.43

mg/l

0.22

294

Lactose intolerance, other/unspecified

408

1.37

1.39

1.7

3.18

3.45

mg/l

0.13

295

Thrombocytopenia, unspecified

881

0.77

1.38

2.1

1.7

9.67

4.51

mg/l

0.76

647

Metabolic disorders

2021

11542

1.05

1.38

2.0

1.7

4.37

4.30

mg/l

0.10

1691

8483

Nonsuppurative otitis media, including avohilmo

780

6246

1.08

1.37

1.6

5.22

4.13

mg/l

1.29

565

4324

Adenocarcinoma and papillary adenocarcinoma of stomach

261

0.57

1.37

1.5

1.8

4.72

4.67

mg/l

—

195

Use of teriflunomide

208

0.52

1.37

1.3

2.0

1.97

2.92

mg/l

—

155

Pseudopolyposis of colon

0.00

1.37

0.0

1.9

—

4.38

—

Exposure to controlled fire, not in building or structure

0.00

1.37

0.0

1.6

—

3.54

—

Pneumococcal septicemia

407

0.66

1.37

1.1

1.8

4.58

3.96

mg/l

0.17

310

Polyarthritis, unspecified

513

0.69

1.37

1.8

3.03

4.93

mg/l

0.72

365

Left side

0.00

1.36

0.0

1.8

—

4.46

—

Corneal pigmentations and deposits

0.00

1.36

0.0

1.8

—

3.15

—

Amputation of thigh

162

0.49

1.36

1.9

1.6

4.18

4.12

mg/l

—

129

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

231

2651

0.87

1.36

1.7

4.02

4.52

mg/l

0.28

174

1953

Other demyelinating diseases of the central nervous system

730

0.74

1.36

1.8

3.49

4.29

mg/l

0.31

529

Other abnormal immunological findings in serum

333

1.40

1.36

1.4

1.8

8.52

3.23

mg/l

0.74

240

Cholangitis (primary sclerosing, PSC)

720

0.74

1.35

1.5

1.8

6.22

3.66

mg/l

0.75

532

Internal derangement of knee

768

7047

1.08

1.35

1.6

1.7

4.69

4.11

mg/l

0.55

596

5071

Type 1 diabetes, strict definition, subgroup 2

0.00

1.35

0.0

1.8

—

3.40

—

Viral hepatitis, including avohilmo

114

1386

0.82

1.35

1.5

1.8

4.40

4.26

mg/l

0.06

1001

Asthma, unspecified (mode)

1181

8008

1.07

1.34

2.0

1.4

6.25

3.51

mg/l

5.24

998

5661

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

570

5222

1.09

1.34

1.7

4.33

4.38

mg/l

0.03

445

3815

Family history of malignant neoplasm

249

2180

1.15

1.34

1.6

1.5

2.69

4.08

mg/l

2.11

183

1582

Secondary hypertension

1083

0.80

1.34

1.5

1.4

3.51

3.47

mg/l

0.02

742

Bacterial, viral and other infectious agents, including avohilmo

179

1529

1.18

1.33

2.2

1.8

5.96

4.61

mg/l

0.50

140

1121

Injury, poisoning and certain other consequences of external causes

1316

6212

1.06

1.33

1.7

1.6

4.71

3.92

mg/l

0.86

991

4291

Follow-up examination after treatment for malignant neoplasms

1089

0.80

1.33

1.8

1.7

7.58

3.95

mg/l

0.73

794

Implicit fungal Sepsis, including avohilmo

112

916

1.23

1.33

2.4

1.7

11.18

4.34

mg/l

2.31

681

Other disorders of cornea

164

1391

1.19

1.33

1.9

1.8

3.82

4.85

mg/l

0.70

125

1047

Faecal incontinence

136

1134

1.21

1.33

1.4

1.7

2.72

3.72

mg/l

1.40

105

838

Other encephalitis

403

0.66

1.32

1.2

1.9

4.01

4.16

mg/l

0.04

295

Other and unspecified glaucoma

580

0.72

1.32

1.5

1.7

3.05

5.06

mg/l

0.98

459

Lymphoid leukaemia

510

0.70

1.32

1.3

1.7

4.22

4.16

mg/l

0.02

394

Benign neoplasm of ovary

277

2444

1.14

1.32

1.5

1.7

3.85

4.29

mg/l

0.33

205

1849

Cluster headache, wide

676

1.27

1.31

1.9

1.7

2.97

4.11

mg/l

0.64

454

Maltreatment syndromes

1073

0.79

1.31

1.8

4.28

4.06

mg/l

0.12

742

Infective dermatitis

132

1579

0.83

1.31

1.7

5.52

3.86

mg/l

0.60

106

1158

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

379

1.37

1.31

2.0

1.7

3.56

3.24

mg/l

0.16

262

Acute appendicitis, no complications

1278

11992

1.06

1.31

1.8

1.7

3.75

4.25

mg/l

1.29

971

8786

Female infertility, tubal origin

110

901

1.23

1.31

1.7

1.8

3.75

4.17

mg/l

0.34

660

Myocardial infarction, with ST-elevation

122

1471

0.83

1.30

2.6

1.7

4.88

5.55

mg/l

0.25

108

1109

Meniscus derangement

1065

6625

1.07

1.30

1.7

4.38

4.15

mg/l

0.23

851

4848

Benign neoplasm: Liver

405

1.35

1.30

1.5

1.7

4.71

3.48

mg/l

0.59

295

Alzheimer’s disease (Atypical or mixed), excluding more controls

329

0.68

1.30

1.3

1.5

4.95

4.78

mg/l

0.04

246

Disorders of optic nerve and visual pathways

131

1565

0.83

1.29

1.9

1.7

5.71

4.65

mg/l

0.31

1145

Other complications of surgical and medical care, not elsewhere classified

176

1506

1.18

1.29

1.7

1.6

4.51

4.18

mg/l

0.15

142

1095

Unspecified kidney failure

895

0.78

1.29

2.6

1.8

9.47

4.71

mg/l

1.24

675

Malignant neoplasm of thyroid gland

1060

0.80

1.29

2.3

1.8

4.18

4.52

mg/l

0.12

786

Other assisted single delivery

434

0.68

1.29

1.1

2.1

3.37

4.43

mg/l

0.41

327

Injuries to the neck

487

4441

1.10

1.29

1.8

1.7

3.60

4.35

mg/l

1.22

378

3220

Ventral hernia

367

3298

1.12

1.28

1.7

7.47

4.17

mg/l

1.49

303

2490

Vitamin B12 deficiency anaemia

120

992

1.21

1.28

1.8

1.7

5.20

4.36

mg/l

0.29

104

751

Tic and related disorders

211

1.50

1.28

1.5

1.8

3.72

3.39

mg/l

0.13

139

Acute suppurative otitis media

676

5826

1.08

1.28

1.7

1.6

4.26

3.97

mg/l

0.29

507

4046

Other or unspecified ileus, impaction or obstruction

182

2115

0.86

1.28

1.6

1.7

7.30

4.57

mg/l

0.45

139

1583

Zoster [herpes zoster], including avohilmo

892

8039

1.07

1.28

2.1

1.7

5.05

4.29

mg/l

0.89

699

5973

Striae atrophicae

220

1.49

1.27

1.8

1.7

2.24

2.81

mg/l

0.41

160

Otitis externa, unspecified

219

1908

1.15

1.27

1.5

1.7

5.07

4.48

mg/l

0.28

175

1404

Malignant neoplasm of head and neck, including Hilmo

1059

0.80

1.27

1.3

1.8

3.64

5.28

mg/l

0.85

785

Toxic effect of ethanol

688

0.75

1.27

1.5

1.8

4.02

4.36

mg/l

0.13

496

Benign neoplasm of breast

208

1806

1.16

1.27

1.5

1.7

3.00

4.30

mg/l

1.81

142

1351

Urolithiasis

475

4328

1.10

1.27

1.7

4.76

4.70

mg/l

0.03

370

3212

Allergic contact dermatitis due to drugs in contact with skin

312

1.40

1.27

1.4

1.9

3.24

3.81

mg/l

0.20

233

Schizophrenia or delusion, excluding more controls

500

5398

0.91

1.26

1.7

4.59

4.22

mg/l

0.47

426

3686

Other intervertebral disc disorders

1793

10176

1.05

1.26

1.8

1.7

4.56

4.08

mg/l

0.85

1412

7360

Encephalitis

434

0.68

1.26

1.2

1.8

3.66

4.03

mg/l

0.11

321

364

1.37

1.26

1.5

1.8

3.38

4.02

mg/l

0.39

235

Gastrointestinal stromal tumor and sarcoma

119

0.41

1.26

1.2

1.7

4.76

5.26

mg/l

—

Other disorders of bladder

150

1269

1.19

1.26

1.7

4.81

4.67

mg/l

0.05

120

943

Struck by thrown, projected or falling objec

105

860

1.23

1.26

1.6

1.8

3.01

4.25

mg/l

1.37

614

Urethritis and urethral syndrome

321

1.39

1.25

1.5

1.8

5.20

5.14

mg/l

0.01

236

Carcinoma in situ of skin of other and unspecified parts of face

537

1.29

1.25

3.2

1.7

6.47

4.56

mg/l

0.31

430

Primary ovarian failure

420

0.68

1.25

1.3

1.7

3.36

3.25

mg/l

0.05

294

Benign lipomatous neoplasm

479

4371

1.10

1.25

1.6

1.8

4.42

4.48

mg/l

0.04

376

3281

Hypertension

1812

9732

1.05

1.25

1.9

1.7

5.81

3.81

mg/l

5.31

1580

6994

Acute pancreatitis (for exclusion)

231

2633

0.87

1.24

1.5

1.7

6.11

4.74

mg/l

0.67

207

1976

Spondylopathies

1383

8632

0.95

1.24

1.8

1.7

5.30

4.13

mg/l

1.98

1119

6353

Emotional disorders starting during childhood or adolescence

120

988

1.21

1.24

1.5

5.09

3.73

mg/l

1.07

674

Alzheimer’s disease (Atypical or mixed)

452

0.70

1.24

1.3

1.5

4.68

5.53

mg/l

0.23

374

Benign neoplasm: Liver/bile ducts

443

1.33

1.24

1.4

1.7

5.11

3.54

mg/l

0.71

324

Disease of hard tissues of teeth, NOS

1005

5609

0.94

1.24

1.9

1.6

5.83

3.92

mg/l

1.98

791

4013

Alzheimer’s disease (Early onset), excluding more controls

285

0.63

1.24

1.3

1.5

13.79

3.95

mg/l

0.84

208

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

443

1.32

1.23

2.6

1.7

6.24

4.47

mg/l

0.55

322

Parkinson's disease

102

1243

0.82

1.23

1.4

1.7

2.92

4.84

mg/l

1.87

957

Malignant neoplasm of endocrine gland

1131

0.81

1.23

2.3

1.8

4.03

4.42

mg/l

0.15

835

Rare circulating lymphoid malignancy, including Hilmo

301

0.63

1.23

1.3

1.7

5.79

4.21

mg/l

0.32

227

Coxarthrosis [arthrosis of hip](FG)

806

5949

0.93

1.23

1.7

4.85

4.08

mg/l

0.80

659

4375

Other sexually transmitted chlamydial diseases, including avohilmo

287

2554

1.13

1.23

1.5

1.6

3.19

4.19

mg/l

2.48

211

1725

Episcleritis

110

908

1.22

1.23

1.4

1.7

4.45

4.86

mg/l

0.16

669

Other disorders of eye and adnexa

277

2458

1.13

1.23

2.2

1.7

3.74

4.27

mg/l

0.46

217

1807

Tic disorders

197

1.50

1.22

1.4

1.8

2.87

2.98

mg/l

0.05

130

Abnormal serum enzyme levels

394

3439

1.11

1.22

1.6

1.7

5.95

4.83

mg/l

0.56

305

2541

Other and unspecified nonorganic psychotic disorders

359

3977

0.90

1.21

1.7

4.38

4.08

mg/l

0.31

309

2840

Benign neoplasm: Choroid

791

1.23

1.21

2.1

1.7

4.12

4.76

mg/l

0.27

600

DVT of lower extremities

212

2425

0.87

1.21

2.0

1.7

4.79

4.65

mg/l

0.05

177

1811

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

172

1479

1.17

1.21

1.6

1.7

4.98

4.13

mg/l

0.39

136

1029

Hypertensive diseases

1811

9738

1.05

1.21

1.9

1.7

5.81

3.81

mg/l

5.32

1579

6998

Allergic contact dermatitis

286

2547

1.13

1.21

1.7

4.19

4.13

mg/l

0.04

239

1886

Oher contracture of tendon (sheath)

2.08

1.20

1.2

1.8

2.11

4.28

mg/l

—

Rotator cuff syndrome

1153

7486

1.06

1.19

1.6

1.7

4.74

4.39

mg/l

0.32

929

5484

Endovascular or surgical operations to intracerebral aneurysms

783

0.77

1.19

1.4

1.8

6.62

4.79

mg/l

0.32

585

Varicose veins

896

7219

0.94

1.19

1.8

1.7

5.23

4.33

mg/l

1.02

708

5488

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

614

1.27

1.19

1.5

1.8

4.01

3.60

mg/l

0.19

444

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS